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Abstract
Patient nonadherence to physicians’ prescribed therapeutic regimen is the greatest
challenge in the effective treatment of patients with diabetes worldwide. Scientific
evidence has revealed that nonadherence to prescribed medication could result in diabetic
complications such as cardiovascular disease, retinopathy, nephropathy, and neuropathic
diabetic foot ulcers. The purpose of this study was to explore predictive relationships
between levels of adherence to antidiabetic medications, patient HbA1c levels, and
diabetic complications among Jamaicans, an understudied population. The research
question that guided this study was: Do the patient level of adherence and HbA1c levels
have any predictive relationship with the severity of diabetic complications
(cardiovascular disease, retinopathy, nephropathy and neuropathic foot ulcer) among
Jamaicans after controlling for age and gender? The theory of planned behavior was used
to guide the study. Data regarding diabetic complications were collected from 119
records during a cross-sectional review of patient dockets. Level of adherence was
determined from an interviewer-administered Morisky 8-item adherence scale. A
multiple regression analysis revealed that lower levels of patient adherence to treatment
and higher HbA1c levels predicted greater severity of cardiovascular disease (p = .000; p
= .000), retinopathy (p = .009; p =.090), nephropathy (p =.007; p =.001) and diabetic
neuropathic foot ulcers (p =.027; p =.001). Findings from this study will contribute to the
knowledge base on diabetic medication nonadherence and may encourage health care
professionals to advocate for better medication adherence strategies among people with
diabetes.
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Chapter 1: Introduction to the Study
Introduction
Health care providers expect individuals living with diabetes mellitus to have an
adequate understanding of the nature of the disease and the treatment options available to
treat the disease. These expectations include understanding the role of antidiabetic
medications in maintaining glycemic control and the consequence of sustained,
uncontrolled hyperglycemia. Individuals living with diabetes should adhere to
physicians’ prescribed treatment regimens (Arifulla, John, Sreedharan, Muttappallymyalil
& Basha, 2014). However, findings from studies have shown that many patients fail to
adhere to treatment recommendations. Consequently, many people with diabetes face
acute and chronic complications (Amado et al., 2015; Kumar, Abbas & Fausto, 2010).
Amado et al. (2015) suggested that nonadherence to treatment compromises a patient’s
ability to achieve optimal treatment. Khan et al. (2012) argued that there are many
reasons why people with diabetes do not adhere to prescribed therapeutic regimens.
These reasons include lack of adequate motivations to take prescribed medication,
inability to adapt to the lifestyle and behavioral changes essential to maintain glycemic
control, and lack of understanding of the severity of diabetic complications. It is also true
that some patients become nonadherent because they are unable to keep appointments
with both the primary and specialist physicians (Khan et al., 2015). Arifulla et al. (2014)
concluded that forgetfulness is one of the most common reasons for nonadherence to
antidiabetic medication. Other researchers have identified factors such as side effects of
antidiabetic medication, treatment regimen complexities, as well as sociodemographic
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status as major factors that influence patient adherence to medication (Arifulla, et al.,
2014; Kassahun, Gashe, Mulisa & Rike, 2016). Low adherence translates to uncontrolled
diabetes mellitus which is problematic because it compromises the immune system and
promotes a number of complications such as retinopathy, nephropathy, cardiovascular
diseases, and diabetic neuropathic foot ulcers (Kaul, Ahmad, Tarr, Kohner & Chibber,
2013).
In this chapter, I will summarize empirical literature that forms the background of
this study. I will also present the problem statement, the purpose of this study and the
research questions. In addition, I will define key terms, discuss the assumptions, scope of
the study, delimitations, limitations, and significance of this study.
Background
Diabetes mellitus (DM) has been defined as a metabolic syndrome that targets
multiple organs (Kumar, Abbas & Fausto, 2010). Kaul et al. (2013) suggested that
diabetes mellitus is a chronic debilitating metabolic disease that has tremendous health,
social, and economic consequences. Papadakis and McPhee (2015) argued that DM is a
metabolic syndrome that is characterized by inappropriate hyperglycemia which occurs
when the pancreatic islet cells malfunction. The dysfunctions of the pancreatic islet cells
translate to deficiencies of insulin secretion or insulin resistance or both (Papadakis &
McPhee, 2010). As a result, doctors make recommendations for prescriptions drugs that
target and correct the metabolic abnormalities to prevent diabetic complications
(Papadakis & McPhee, 2015).
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According to Khadar et al. (2015) Type 2 DM is characterized by a combination
of multiple pathologies which includes insulin resistance, insufficient insulin secretion,
and inappropriate glucagon secretion. These complex abnormalities manifest as an array
of metabolic dysfunctions that are characterized by hyperglycemia, high levels of free
fatty acids, elevated levels of pro-inflammatory cytokines in plasma, decreased glucose
transport into muscle cells, increased breakdown of fat, and elevated hepatic
gluconeogenesis. All these metabolic abnormalities are common in both Type 1 and Type
2 DM (Khardori et al., 2015). Kumar, Abbas, and Fausto (2010) explicated that DM is
more than a disease; rather, it is a group of coordinated metabolic disorders that share a
common denominator which is hyperglycemia. Uncontrolled sustained hyperglycemia
may have profound consequences that may include damage to major organs and
metabolic dysregulations (Kumar et al.,2010).
According to the American Diabetes Association (2014) insulin synthesis,
secretion, and sensitivity are key to glycemic control; an interruption in any part of the
insulin process could evolve into Type 2 DM. Most common diabetic complications are
due to insulin dysregulations and those complications include diabetic retinopathy,
nephropathy, cardiovascular disease, and diabetic neuropathic foot ulcers (Kumar et al.,
2010). Medical authorities agree that patient adherence to medical treatment of diabetes
prevents debilitating diabetic complications (Kumar et al., 2010; Arifulla et al., 2014).
Medication adherence is defined as the degree to which a person with diabetes patient
takes prescribed medication as recommended by the attending physician or health care
provider (Arifulla et al., 2014).
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The World Health Organization (WHO) survey on the global prevalence of DM
revealed that the global burden of diabetes was at an all-time high in 2012 (WHO, 2014).
Findings from the survey revealed that the worldwide prevalence of DM in 2012 was
about 9% among individuals from 18 years of age and above (WHO, 2015). The data also
showed that about 1.5 million deaths worldwide were directly related to diabetes in 2012
(WHO, 2015). Diabetes mellitus was projected by the WHO to be the seventh leading
cause of death worldwide by the year 2030 (WHO, 2015). The WHO also reported that
approximately 80% of diabetes-related deaths occur among individuals who are in low
and middle socioeconomic levels (WHO, 2015).
The International Diabetic Federation (IDF) suggested that the number of
individuals with DM may rise from about 366 million individuals in 2011 to about 552
million people by the year 2030. The IDF also indicated that about 183 million
individuals worldwide who are currently living with diabetes may be unaware of their
status (Lysenko & Laakso, 2013). According to Hirst (2013) about 5.1 million deaths
worldwide were directly attributed to diabetes mellitus in 2013, with a financial burden
estimated at $548 billion in the same year worldwide.
The Center for Disease Control and Prevention (CDC) reported that in the United
States about 29.1 million (9.3%) people have diabetes in 2013(CDC, 2016). The
prevalence of DM is higher among some racial/ethnic groups than others; American
Indians and Alaskan Natives (16.1%) have the highest prevalence of diabetes mellitus
followed by non-Hispanic Blacks (12.6%). The group that is least affected by diabetes is
non-Hispanic White 7.1%; (American Diabetes Association, 2016).
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Comparatively, the prevalence of DM among Jamaicans is as high as the
prevalence in the United States and the rest of the world (Ferguson, Tulloch-Reid &
Wilks, 2010). The prevalence rates of DM in Jamaica vary according to variables such as
age and gender. The prevalence of diabetes mellitus in Jamaica among individuals 15–24
years of age is 1.2% while it is 29.6% among older people aged 65–74 years. Ferguson et
al. (2010) indicated that the prevalence of diabetes mellitus among individuals with
normal BMI is 4% while it is approximately 13% among individuals who are obese.
Ferguson et al. (2010) which is the most current published study on DM in Jamaica also
indicated that approximately 9.3% of women have diabetes mellitus as compared to 6.4%
of men in Jamaica. A total of 2.8% Jamaicans had impaired fasting glucose which is also
known as prediabetes during 2007/2008 survey.
According to Aschner et al. (2016) appropriate medical intervention during the
prediabetes period could delay the onset of diabetes. Early diagnosis coupled with
adequate intervention and adherence to medical treatment could further prevent the
development of diabetic complications. Also, data from the United Kingdom Prospective
Diabetes Study (UKPDS) showed that tight glucose control as evidenced by normal
HbA1C levels decreased the incidence of diabetic complications. The UKPDS results
also showed that after the onset of diabetes, there was a continuous decline in the number
of the beta-cells functioning irrespective of the intervention method deployed by an
attending physician (UKPDS, 2015). The viability of the beta cells and their functionality
continued to regress as patients advanced in age and the number of years after diagnosis
increased. Antidiabetic medications are given to help maintain optimal glycemic control
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in presence beta cell decline and dysfunction. However, when a patient fails to adhere to
the established treatment guidelines, it makes tight glycemic control difficult to achieve
(Papadakis et al., 2015). The American Diabetes Association (ADA) recommends several
guidelines regarding the treatment and management of diabetic complications. ADA
recommends that HbA1c should be controlled at 7.0% or lower. Reducing HbA1C levels
7.0% or less significantly reduces incidences of diabetic complications. After the onset of
diabetes, the optimal HbA1C levels can only be achieved through patient adherence to
medical treatment regimens. Optimal HbA1C levels can only be achieved after the onset
of diabetes through treatment adherence (ADA, 2016). If a patient fails to adhere to
prescribed treatment or if a physician fails to adhere to recommended standards of care as
outlined by the ADA, diabetic complications for patients become eminent. In the case of
Type 1 DM, the beta cells are nonexistent from onset. In Type 2 DM, the beta cells will
continue to regress numerically and functionally as diabetes progresses with or without
treatment, hence making treatment adjustments and adhering to prescribed treatment the
key to preventing diabetic complications (ADA, 2016). Kumar et al. (2010) postulated
that irrespective of the fact that there are disparities in the pathophysiology and
pathogenesis of various forms of diabetes, most of the complications (microvascular,
macrovascular, and neuropathic) accelerate due to nonadherence to antidiabetic
medications. Khardori et al. (2015) further suggested that regardless of the type of
diabetes, hyperglycemia appeared to be the determinant of microvascular and metabolic
complications. Hence medication adherence that prevents hyperglycemia is effective in
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decreasing the incidence of diabetic complications and even in enervating the severity of
existing complications (Dunn, 2016). Taskaya (2015) suggested that,
in diabetes management, providing glycemic control plays a main role in care and
achieving it depends on the patient adherence to medical treatment faithfully.
Therefore, adherence is the extent to which the patient’s medication taking
behavior corresponded with the prescribed medication regimen (p. 602).
Studies have shown that nonadherence to treatment among people with diabetes
prevails across age groups; even young individuals with Type 1 diabetes experience
challenges in adhering to recommended treatment regimens (Costa et al., 2015; Cox &
Hunt, 2015). Kivimaki et al. (2013) suggested that there is substantial reduction in
adherence to medication after individuals enter retirement age; change in socioeconomic
status and comorbidities may contribute to the reduction in adherence level among this
group. Khardori, et al. (2015) elucidated that the microvascular and macrovascular
diabetic complications include cardiovascular disease, diabetic retinopathy (DR), diabetic
nephropathy (DN), and diabetic neuropathic foot ulcer.
Diabetic retinopathy (DR)
DR is defined as a major complication of DM that manifests when the blood
vessels in the retina are damaged and the blood vessels start leaking blood and other
fluids into the retina (American Optometric Association [AOA], 2017). The progressive
leak of blood and fluid into the retina causes the retinal tissues to swell, and if left
untreated, diabetic retinopathy could cause blindness. Indications of DR include blurred
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vision, seeing a dark spot in the center of vision, difficulty seeing well at night, and
seeing spots or floaters (AOA, 2017)
According to Khaw, Shah, and Elkington (2010), DR may present as gradual
onset of visual loss which is an indication of long duration of uncontrolled
hyperglycemia. Diabetic retinopathy (DR) may be classified as mild, moderate,
proliferative, or nonproliferative (Bhavsar & Khardori, 2016). Nonproliferative diabetic
retinopathy is characterized by micro aneurysm, dot hemorrhage and hard yellow
exudates with well-defined edges (Khaw et al., 2010). Macula edema is usually present
and may lead to diminished visual acuity. Diabetic maculopathy, also known as diabetic
retinopathy at the macula, is the leading cause of blindness in patients with Type 2
diabetes mellitus. The proliferative DR is epitomized by the presence of new blood
vessels on the retina that seem to proliferate into the vitreous cavity (Khaw et al., 2010).
The new blood vessels are highly susceptible to bleeding, thus resulting in a sudden
decrease in vision and production of contractile membranes. The contractile membranes
gradually detach the retina which leads to blindness. In some cases, the hemorrhage may
lead to occlusion of the drainage angle of the anterior chamber causing rubeotic
glaucoma (Khaw et al.., 2010).
Diabetic nephropathy (DN)
Diabetic nephropathy (DN) is a complication that has been diagnosed in
individuals living with either Type 1 or Type 2 diabetes mellitus (DM) and typically
starts manifesting about 10 to 15 years following onset of DM (Kumar et al., 2010). The
pathology of DN is typified by distinct histologic changes that usually occur in the
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glomeruli. Findings from studies have shown that diabetic nephropathy is the leading
cause of end stage renal disease (Batuman & Khardori, 2016; Kumar et al., 2010).
Chronic hyperglycemia coupled with hemodynamic crisis have been identified as triggers
of diabetic nephropathy (Batuman & Khardori, 2016). Findings from research have
revealed that accumulation of glucose and other metabolites work in synergy with
increased vascular permeability to exacerbate extracellular matrix accumulation and
proteinuria observed in diabetic nephropathy (Batuman & Khardori, 2016).
Cardiovascular disease
Cardiovascular disease is defined as a syndrome of heart conditions that affect the
structure and function of the heart due to persistent hyperglycemia, hyperlipidemia, and
elevated levels of amino acids (Fontes-Carvalho, Ladeiras-Lopes, Bettencourt, LeiteMoreira & Azevedo, 2016). Common forms of cardiovascular diseases that are associated
with DM include ischemic heart disease, heart failure, and stroke. Acceleration of the
atherosclerosis of the aorta, medium size, and larger size arteries is the hallmark of DM.
A major complication of atherosclerosis is myocardial infarction (MI) that is localized at
the coronary arteries (Kumar et al., 2010). Hyaline arteriolosclerosis, a vascular lesion
that is also associated with hypertension is more common and more devastating among
people living with diabetes mellitus. Diabetic microangiopathy is another form of
cardiovascular disease common among diabetics. The pathology involves diffuse
thickening of various basement membranes and selective thickening of the capillaries of
the renal medulla, renal glomeruli, retina, skeletal muscles, and the skin. The thickening
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of the capillaries is directly responsible for the extensive leaky nature of the cardiac
capillaries (Kumar et al. 2010).
Diabetic Neuropathy and Foot Ulcers
Diabetic neuropathy is the most common complication of diabetes mellitus, with
about 50% of older patients with Type 2 DM affected (Papadakis et al., 2015). Diabetic
neuropathy is classified as peripheral neuropathy (distal symmetric polyneuropathy and
isolated peripheral neuropathy) or autonomic neuropathy (Kumar et al., 2010; Papadakis
et al., 2015). Other types of diabetic neuropathy include proximal neuropathy and focal
neuropathy (WebMD, 2017). The peripheral diabetic neuropathy affects the legs, feet and
in some very rare cases affects the arms, abdomen and the back. When peripheral diabetic
neuropathy manifests as a distal symmetric polyneuropathy the patient may experience
loss of function that appear in a stocking-glove pattern due to an axonal neuropathic
process. The axonal neuropathic process involves loss of long nerves that results in motor
and sensory conduction delay in peripheral nerve and even absence of ankle jerks
(Papadakis et al., 2015).
Sensory involvement usually occurs first and is in general bilateral, symmetric
and associated with dulled perception of vibration, pain and temperature the
denervation of the small muscles of the foot results in clawing of the toes and
displacement of fat pad (Papadakis et al., 2015, p.1215).
The complex changes that occur in the foot because of diabetic neuropathy result
in the alteration of the foot biomechanics. Extensive biomechanical variations in the foot
promotes high pressure areas that rupture and become ulcerated, and such areas have
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been implicated in most diabetic foot deformities (WebMD, 2017). Diabetic neuropathic
foot ulcer consists of wounds that occurs because of compromised vasculatures due to
poor perfusion. Diabetic neuropathic foot ulcers can be triggered by injury and/or
infections in the high-pressure areas (Papadakis et al., 2015). Kumar et al. (2010)
indicates that the pathogenesis of diabetic foot ulcer is typified by inadequate circulation
to the lower extremities coupled with microvascular disease, in association with
diminished sensation due to neuropathy. Infections of diabetic foot ulcer are major
triggers of a span of broad spectrum of complication pathology ranging from superficial
cellulitis to osteomyelitis.
Diabetes mellitus is a complex metabolic syndrome that could trigger several
types of complications such as diabetic retinopathy (DR), diabetic nephropathy (DN),
cardiovascular disease and diabetic neuropathic foot ulcers. However, when patients and
attending physicians adhere to recommended standards of care for diabetes, the risk of
these complications for individuals declines to a bearable minimum (ADA, 2016). On the
other hand, patient nonadherence to diabetic treatment exacerbates the excruciating
problems that are linked to diabetes (ADA, 2016).
Problem Statement
According to Amado et al. (2015) nonadherence to physician- recommended
therapeutics among people with diabetes is a global problem that deserves more attention.
Kivimäki et al. (2013) argued that while antidiabetic medications have been shown to be
effective in decreasing diabetic complications, patient nonadherence to taking medication
is common, and the resultant diabetic complications are on the rise. Contreras et al.
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(2011) reported that 25% of people with diabetes who participated in their study were
therapeutically nonadherent. Amado et al. (2015) suggested that nonadherence to
treatment plan compromises patient’s opportunity to achieve optimal glycemic control.
Khan et al. (2012) argue that when the health seeking behaviors of a people with diabetes
lack congruence with recommendations of a health care provider, the result is usually
diabetic complications.
Jamaica has a high prevalence of Type 1 and Type 2 diabetes mellitus (DM).
According to the 2007/8 Jamaica Health and Life Style (JHLS) Survey, 7.9% of the
population of Jamaica had DM and additional 2.8% of the population was living with
impaired fasting glucose. Ferguson, Tulloch-Reid, and Wilks (2010) stated that there are
only few published studies regarding adherence to diabetic medication treatment plans
and diabetic complications in Jamaica and the Caribbean region. As a result, there is a
gap in the literature regarding the relationships between levels of adherence to medical
treatment and complications from diabetes in Jamaica.
Purpose of Study
In this quantitative, correlational study, I explored the relationship between levels
of adherence to antidiabetic medications, HbA1c levels and diabetic complications
(cardiovascular disease, diabetic retinopathy, diabetic nephropathy, diabetic neuropathic
foot ulcer). This study revealed that levels of adherence to antidiabetic medication
negatively correlates with diabetic complications while HbA1c levels positively
correlates with diabetic complications. The outcome of this study may be key to creating
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needed awareness and possibly encourage other researchers to help conduct more
extensive study in this area.
Research Questions and Hypotheses
I examined the predictive relationships between patient level of adherence to
therapeutic regimens (physician prescribed diabetic medication), HbA1c levels and
diabetic complications. Levels of adherence to treatment and HbA1c were the
independent variable while diabetic complications such as cardiovascular disease,
retinopathy, nephropathy and neuropathic foot ulcer are the dependent variables. The
control variables include age and gender.
Research Question 1 (RQ1): How well do patient adherence to antidiabetic
medication and HbA1c levels (glycemic control) predict the severity of retinopathy
among people with diabetes in Jamaica after controlling for age and gender?
Null Hypothesis (H01): Patient adherence to antidiabetic medication (Morisky 8item Adherence Scale) and HbA1c levels (glycemic control) are not statistically
significant predictors of the severity of retinopathy among people with diabetes in
Jamaica, after controlling for age and gender.
Alternative Hypothesis (Ha1): Patient adherence to antidiabetic medication
(Morisky 8-item Adherence Scale) and HbA1c levels are statistically significant
predictors of the severity of retinopathy among diabetic patients in Jamaica, after
controlling for age and gender.
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Research Question 2 (RQ2): How well do patient adherence to antidiabetic
medication and HbA1c levels (glycemic control) predict the severity of nephropathy
among people with diabetes in Jamaica, after controlling for age and gender?
Null Hypothesis (H02): Patient adherence to antidiabetic medication (Morisky 8item Adherence Scale) and HbA1c levels are not statistically significant predictors of the
severity of nephropathy among people with diabetes in Jamaica, after controlling for age
and gender.
Alternative Hypothesis (Ha2): Patient adherence to antidiabetic medication
(Morisky 8-item Adherence Scale) and HbA1c levels are statistically significant
predictors of the severity of nephropathy among people with diabetes patients in Jamaica,
after controlling for age and gender.
Research Question 3 (RQ3): How well do patient adherence to antidiabetic
medication and HbA1c levels predict the severity of cardiovascular disease among people
with diabetes in Jamaica, after controlling for age and gender?
Null Hypothesis (H03): Patient adherence to antidiabetic medication (Morisky 8item Adherence Scale) and HbA1c levels are not statistically significant predictors of the
severity of cardiovascular disease among people with diabetes in Jamaica, after
controlling for age and gender.
Alternative Hypothesis (Ha3): Patient adherence to antidiabetic medication
(Morisky 8-item Adherence Scale) and HbA1c levels are statistically significant
predictors of the severity of cardiovascular disease among people with diabetes patients
in Jamaica, after controlling for age and gender.
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Research Question 4 (RQ4): How well do patient adherence to antidiabetic
medication and HbA1c levels predict the severity of neuropathic foot ulcer among people
with diabetes in Jamaica, after controlling for age and gender?
Null Hypothesis (H04): Patient adherence to antidiabetic medication (Morisky 8item Adherence Scale) and HbA1c levels are not statistically significant predictors of the
severity of neuropathic foot ulcer among people with diabetes patients in Jamaica, after
controlling for age and gender.
Alternative Hypothesis (Ha4): Patient adherence to antidiabetic medication
(Morisky 8-item Adherence Scale) and HbA1c levels are statistically significant
predictors of the severity of neuropathic foot ulcer among people with diabetes patients in
Jamaica, after controlling for age and gender.
The independent variables in this study were levels of adherence to recommended
Antidiabetic medications determined by responses from Morisky 8-item Adherence Scale
and HbA1C levels. The dependent variables were cardiovascular disease, retinopathy,
nephropathy, and diabetic neuropathic foot ulcers.
Theoretical framework
Nonadherence to prescribed treatment could be viewed as a cognitive selfregulated behavior that could be predicted in accordance to the theory of planned
behavior (Janzen, 1985). The theory of planned behavior was proposed by Icek Ajzen in
1985 in an article captioned "From intentions to actions: the theory of planned behavior"
(Ajzen, 1985). The theory is an extension of the theory of the reasoned action which
addresses the challenges of incomplete volitional control (Van Camp, Bastiaens, Van
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Royen, & Vermeire, 2016). The theory of planned behavior suggests that human behavior
is guided by the following three conceptual elements: (a) beliefs about the likely
consequences of behavior (behavioral beliefs), (b) normative beliefs or the notion that
expectations of other people influence a person’s behaviors and (c) volitional control, or
beliefs which indicate that an individual can decide at will to perform or not perform a
behavior (Ajzen, 1985). The fundamental principle of planned behavior theory is that
behavioral beliefs or attitudes towards treatment plan translate into a healthy or unhealthy
behavior, and that such behavior is predictable (Ajzen, 1985).
The theory of planned behavior explicates that behavioral intentions is a major
determinant of behavior because people seem to consider the implications of their actions
before engaging or refraining in diverse kinds of behaviors. A person’s intentions,
coupled with perceptions of behavioral control contribute to variance in actual behavior
(Sharma & Romas, 2012). Sharma and Romas (2012) posited that past behaviors could
be used to make prediction about future behavior. Findings from several studies have
shown that the theory of planned behavior has been quite useful in making predictions
about future behaviors (Sharma & Romas, 2012).
Nature of Study
In this quantitative, correlational study, I examined the predictive relationships
between levels of adherence to antidiabetic medication, HbA1c and diabetic
complications among diabetics in Jamaica. I used the cross-sectional design for this
study. The cross-sectional design is one of the most commonly used research designs in
health promotion and hence the most appropriate design for this study. In cross-sectional
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design the data are usually collected at one point hence the time is fixed, and therefore it
is considered the hallmark of this study design (Creswell, 2014).
Definitions
Definitions are presented to clarify terms used in this study and to assist readers to
understand why such terms were use; these terms are listed below.
Diabetes Mellitus: Khardori et al. (2015) defined diabetes mellitus as a chronic
metabolic disorder characterized by a combination of insulin resistance at the peripheral
level and inadequate insulin secretion by the beta cells in the pancreas or absence of
insulin caused by autoimmune destruction of the beta cells.
Medication adherence: Hugtenburg et al. (2013) defines medication adherence as
the degree to which an individual is able conform to a physician’s prescribed treatment
regimens (80% -100%).
Medication nonadherence: Medication nonadherence is a diagnosable and
treatable medical condition that could deprive a patient the opportunity to recover or the
ability to mitigate the complications of disease (Marcum et al., 2013). Nonadherence is
determined when a patient takes medication less than 80% of the recommendation.
Diabetic retinopathy (DR): Diabetic retinopathy (DR) is defined as a major
complication of inadequately controlled diabetes mellitus that manifests when the blood
vessels in the retina are damaged (Kapadakis, 2015).
Diabetic nephropathy (DN): Diabetic nephropathy is a complication that is
characterized by persistent microalbuminuria, progressive decline in glomerular filtration
rate (GFR) and elevated arterial blood pressure (Kumar, Abbas & Fausto, 2010).
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Cardiovascular disease: Cardiovascular disease is defined as a syndrome of heart
conditions that affect both the structure and function of the heart due to persistent
hyperglycemia, hyperlipidemia and elevated levels of amino acids (Fontes-Carvalho,
Ladeiras-Lopes, Bettencourt, Leite-Moreira & Azevedo, 2016).
Diabetic neuropathic foot ulcer:. Diabetic neuropathic foot ulcers are wounds that
occur because of compromised vasculatures that results into inadequate perfusion via the
microcirculatory network (Kumar, Abbas & Fausto, 2010).
Assumptions
There are several assumptions associated with this research. It was my assumption
that the archived data, the information and the variables in the database were complete,
accurate and that the hospital collected them using interviewer administered Morisky 8item Adherence Scale and laboratory results of HbA1c of all the participants. It was my
assumption that the respondents were honest and that inability to recall frequency of
nonadherence did not affect the overall data. I assumed that other factors such as physical
inactivity, diet, genetics and socioeconomic status do not contribute to the development
of diabetic complications. I assumed normal distribution of the dependent (y) variable
which are the diabetic complications and that there was linear relationship between x
(independent variable) and y (dependent variable). I also assumed independent
observations and homoscedasticity of the data collected (Grove & Cipher, 2017).
Scope and Delimitations of Study
I examined predictive relationship between patient adherence to antidiabetic
medications and diabetic complications. Adherence to antidiabetic medication
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determined by HbA1c levels and patient responses from Morisky-8 scale were the
independent variables. The dependent variables were the following diabetic
complications: cardiovascular disease, retinopathy, nephropathy and diabetic neuropathic
foot ulcer. Age and gender were the control variables. It was beyond the scope of this
study to address other mitigating factors that may contribute to the onset or prognosis of
diabetic complications. In addition, diabetic complications such as diabetic ketoacidosis,
hyperosmolar hyperglycemic state, diabetic enteropathy, diabetic peripheral neuropathy
are the delimitations of this study.
Limitations of Study
A major limitation of this study was that there are many other factors such as
sedentary lifestyle, smoking cigarettes, obesogenic diet options, advanced age, late or undiagnosed diabetes mellitus, use of complementary or alternative medicines and even comorbidities that could contribute to the manifestations of diabetic complications (Gemeay
et al., 2015). The afore mentioned variables could also exacerbate the diabetic
complications (Papadiski, 2015).
Another limitation was that I used secondary data which might not be a true
representation of the Jamaican society. The sample size used for this study was 119 and
could be a constraint on the generalizability of this study. Responses to the Morisky 8item Adherence Scale questionnaire were self-reported and subjected to selective
memory, telescoping, attribution and/or exaggeration (Brutus et al., 2012). Lack of prior
studies on this topic in the Caribbean in recent years to reference as empirical data was
also a limitation to this study.
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Significance of Study
Ferguson et al. (2010) indicated that a study on nonadherence to therapeutic
regimens among Jamaican diabetics has never been done, and only very few studies of
this nature have been conducted in Jamaica. Ferguson et al. (2010) also indicated that
there are only few published data regarding diabetic complications in Jamaica and
Caribbean region. The authors argue that such data will be helpful in planning effective
strategies to combat diabetes mellitus. Hence it is essential to know whether the diabetic
complications that are diagnosed among this population correlates with nonadherence to
the recommended therapeutics. The potential positive social change impact of this study
will be to inform other public health professionals to create public awareness about the
consequences of patient nonadherence to medical treatment for diabetes.
The information from this study would provide empirical evidence of the link
between patient adherence or nonadherence to diabetic medication and diabetic
complications among Jamaicans diagnosed with diabetes. Social workers and other health
care professionals could use the information to advocate for specific interventions that
focus on improving patient adherence to prescribed medications. Those interventions
would then be a major step toward combating the epidemic of diabetic complications. An
additional social change outcome would be improving the health outcomes for diabetic
patients in Jamaica.
Summary
Diabetes mellitus is a chronic metabolic disorder that has become a global
epidemic that leads to serious health implications (Shivashankar et al., 2016). The 2014
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National Diabetes Statistics report indicates that 29.1 million individuals or 9.3 percent of
American population is living with diabetes mellitus while only 21 million people are
diagnosed with the disease, and 8.1 million undiagnosed (CDC, 2016). The burden of
diabetes in many societies including Jamaica is great, but results of many studies have
shown that adherence to recommended treatment has been effective in slowing down the
progress of the disease and preventing diabetic complications (ADA, 2016).
Diabetes treatment demands active involvement of the patients. However,
nonadherence to physicians prescribed therapeutic regimen is the greatest challenge in
the effective treatment of diabetic patients worldwide and has become a growing concern
for all health care providers (Remington et al., 2010). Accumulation of scientific
evidence points to the fact that nonadherence to prescribed medication is responsible for
the numerous diabetic complications that have become prevalent among diabetic patients
(Remington et al., 2010; Kumar et al., 2010). Results from empirical studies have shown
that adherence to recommended antidiabetic drugs helps to achieve tight glycemic
control. Adherence to antidiabetic medications also helps to decrease systemic,
glomerular hypertension, inflammatory process and prevents metabolic syndrome
(Kumar et al., 2010; Papadakis et al., 2015). In this quantitative study, I examined the
predictive relationships between adherence to medical treatment for diabetes, HbA1c
levels and diabetic complications among diabetics in Jamaica. I used the cross-sectional
design for this study. The data was collected at one point, hence the time is fixed and
considered the hallmark of this study design (Creswell, 2014).
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In chapter 2, I will review current literature on nonadherence to antidiabetic
medications and diabetic complications. Findings from studies have revealed that
nonadherence to antidiabetic medications may be associated with various diabetic
complications. I will start the chapter with a preface of nonadherence to antidiabetic
medications and progress to literature search strategy, theoretical foundation and
framework, review of key variables, risk factors and epidemiology of diabetes and
nonadherence.
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Chapter 2: Literature Review
Introduction
Patient nonadherence is defined as a patient’s failure to adhere to a prescribed
course treatment by the attending physician (MedicineNet, 2018). Nonadherence to
physician prescribed antidiabetic medication is a complex and multidimensional problem
(Hugtenburg et al., 2013). According to Hugtenburg et al. (2013), diabetic patient
nonadherence to treatment can consist of any of the following actions: (a) patient refusal
to fill or refill medication prescriptions in a timely manner which results in failure to
commence treatment or a gap during the period of treatment, (b) patient using more
medications or less medications than what is prescribed by a physician, and (c) patient
deviating from the doctor prescribed schedule for taking medications. Irrespective of the
reason for patient nonadherence, a major consequence of nonadherence is that the
individual will not be able to obtain an optimal pharmacotherapeutic benefit;
consequently, the individual faces increased diabetic complications (Hugtenburg, 2013).
Studies have shown that antidiabetic medications are essential in preventing the
complications of diabetes mellitus (Blackburn, Swidrovich & Lemstra, 2013;
Hugtenburg, 2013). Diabetic complications associated with medication nonadherence
have been attributed to increased mortality among people with diabetes and have caused
unbearable healthcare cost burdens to many countries (Blackburn et al., 2013).
Nonadherence to antidiabetic medication is a serious public health challenge and has
become a priority for governments and healthcare providers around the globe. According
to Blackburn et al. (2013), factors such as concurrent chronic use of multiple medications

24
to treat numerous comorbidities, advancing age, socioeconomic factors, gender, and even
fear of side effects of antidiabetic medications all contribute to nonadherence.
Nonadherence to medication among diabetic patients is high and even alarming when
compared to other conditions, and it is inextricably linked to multiple hospitalizations and
diabetic complications (Blackburn et al., 2013).
The purpose of this study was to explore any correlations between nonadherence
(low levels of adherence and high levels of HbA1c) and diabetic complications
(cardiovascular disease, diabetic retinopathy, diabetic nephropathy, and neuropathic
diabetic foot ulcers). In this chapter I will cover the strategies that I used in the search of
literature, the theoretical foundation, and the framework of this study. I will also review
related current literature on the association of nonadherence to antidiabetic medication
with cardiovascular diseases, diabetic retinopathy, diabetic nephropathy, and diabetic
neuropathic foot ulcer.
Literature Search Strategy
I conducted an extensive search of relevant literature digitally through electronic
medical and public health databases such as MEDLINE, CINAHL, American Diabetes
Association (ADA), Medscape, Univadis, New England Journal of Medicine as well as
through Walden University library database. I used search terms such as diabetes mellitus
Type 1, diabetes mellitus Type 2, diabetic complications, retinopathy, nephropathy,
cardiomyopathy, and diabetic foot to conduct the literature search. I obtained other
sources and articles for this literature review traditionally through printed versions of
professional journals such as the Journal of American Pathologists, as well as numerous
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medical books on pathologic basis of disease, public health epidemiology and
environmental health. All books, journals, and electronic print materials used in this
study were published within the last 6 to 7 years.
Theoretical Foundation
I used the theory of planned behavior as the theoretical framework for this study.
According to Ajzen (1985), the theory of planned behavior explicates that human actions
are guided by three major considerations which include: a) beliefs regarding the likely
outcomes of a behavior and the evaluations of the belief’s outcomes; b) normative
beliefs, which are expectations of others and motivation to conform with these
expectations; and c) control beliefs, which states that the presence of influencing factors
may enable or hinder manifestation of a behavior. When attitude towards behavior is
combined with subjective norm coupled with perception of behavioral control, it results
in the development of a behavioral intention (Rich, Brandes, Mullan, & Hagger, 2015).
The theory of planned behavior has proven to be useful in predicting behavior such as
adherence. Levels of adherence could be predicted based on consistent forms of attitude,
subjective norm, perceived behavioral control, intention and previous behaviors (Rich et
al., 2015).
According to Van Camp et al. (2016), planned behavior could potentiate
satisfactory or unsatisfactory behaviors, good or bad intentions, positive life-changing
attitudes, or negative self-destructive attitudes that could translate to variance in actions.
According to Sharma and Romas (2012), studies have shown that people seem to
consider the implications of their action before engaging or refraining from various kinds
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of behaviors. Nonadherent behaviors could be predicted with a high degree of accuracy
by closely examining patient’s attitudes toward medical treatment, their perceived
behavioral control and subjective norms. When a patient has a sufficient behavioral
control coupled with good intentions the patient is most likely go to adhere to treatment
regime (Sharma & Romas, 2012).
Literature Review Related to Key Variables
Diabetes mellitus (DM)
DM is defined as a chronic metabolic syndrome that is characterized by
hyperglycemia, hyperlipidemia, and elevated amino acids (Kumar et al., 2010). Kaul,
Tarr, Ahmad, and Chibber (2013) suggested that diabetes mellitus is a chronic
debilitating metabolic disease that has tremendous health consequences. Diabetes
mellitus compromises the immune system, promotes retinopathy, nephropathy,
neuropathy (somatic and autonomic), and cardiovascular diseases. Khardori et al. (2015)
defined diabetes mellitus as chronic metabolic disorder that has been classified as Type 1
and Type 2. According to Khardori et al. (2015), Type 1 diabetes mellitus is a chronic
disease that affects multiple organs and the nervous system. Type 1 diabetes affects the
metabolism of carbohydrate, fat, and protein due to the absence of insulin caused by
autoimmune destruction of the beta cells which translates to metabolic catastrophe unless
it is adequately managed. Type 1 diabetes mellitus can occur at any age, but it is more
common among juveniles; however, adults in their late 30s and early 40s have been
diagnosed of Type 1 diabetes mellitus.
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Type 2 diabetes is characterized by a combination of insulin resistance at the
peripheral level and inadequate insulin secretion by the beta cells in the pancreas.
According to Khardori et al. (2015) insulin resistance is a major complication of
sustained elevated levels of free fatty acids and pro-inflammatory cytokines in the
plasma, which decreases glucose transport into muscle cells and results in elevated
hepatic glucose production. Patients living with Type 2 DM do not unequivocally depend
on insulin for life; however, they may need insulin as the disease progresses and or when
the pancreas completely fails to secret insulin (Kumar et al., 2010).
Type 2 diabetes mellitus was originally considered adult-onset diabetes but
findings from studies have shown that the epidemic of obesity coupled with sedentariness
among children in certain populations has resulted in Type 2 DM (CDC, 2016; Kumar et
al., 2010). However, individuals who are 40 years and older who have a family history of
DM are at greater risk for Type 2 DM (ADA, 2016). Empirical data show that Type 2
diabetes increases the risk of coronary heart disease (CHD) in women more than in men
(ADA, 2016).
Papadakis and McPhee (2015) maintained that diabetes mellitus is a metabolic
syndrome that is characterized by hyperglycemia due to malfunction of the pancreatic
islet cells that translates to paucities of insulin secretion and or insulin resistance. Kumar
et al. (2010) argued that diabetes mellitus is more than a disease as it presents with a
group of synchronized metabolic maladies that share a common denominator, which is
hyperglycemia. Results from studies have shown that sustained hyperglycemia translates
into myriad of organ related complications and even further metabolic dysregulations.
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Insulin is a metabolic hormone that is essential and indispensable; deficiency or absence
of insulin secretion that is left untreated or uncontrolled results in various forms of
diabetic complications.
Report from Diabetes complications and control Trial (DCCT) revealed that
“a near normalization of blood glucose resulted in a delay in the onset of
diabetes. Data in the same study showed that normalization of blood glucose
contributed to a major slowing of the progression of established microvascular
and neuropathic diabetic complications” (p. 1192).
Results from the study highlights the fact that adhering to recommended
therapeutics could be successful in preventing diabetic complications (Papadakis et al.,
2015).
Patient Nonadherence and Diabetic Complications
According to Chang, Chien, Lin, Chiou, and Chiu (2015) patient nonadherence to
antidiabetic treatment translates to poor glycemic control which has been associated with
end-stage renal disease (ESRD) among diabetics. Chang et al. (2015) explored the
correlations between antidiabetic medication nonadherence and the risk of developing
ESRD among patients who were newly diagnosed with diabetes mellitus. They extracted
archived data from the Taiwan National Health Insurance Research Database (NHIRD)
and identified 559,864 records that met the inclusion criteria for the data analysis. The
records that met the criteria for the study belonged to individuals between the ages of 20
to 85 years during the study. Chang et al. (2015) indicated that records show that 16695
patients developed end stage renal disease (ESRD) during the 6-year study period. The
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researchers found that patients who did not adhere to antidiabetic medication therapy had
higher risk of developing ESRD when compared to patients who adhered to antidiabetic
medication therapy. The outcome of the study also revealed that adherence to antidiabetic
medication could prevent the acceleration of the loss of renal function and even ESRD
among diabetic patients.
According to Busko (2014), nonadherence to antidiabetic medication results in
sustained hyperglycemia which has long term effect on the microvasculature and most
major organs. Living with either Type 1 or Type 2 diabetes for more than 10 years has
been associated with microvascular and macrovascular complications such as
cardiomyopathies, nephropathy, or even retinopathies. These recent findings provide a
unique opportunity to health care providers to refocus efforts towards intense or
aggressive management of hyperglycemia from the time of diagnosis of diabetes among
younger population to minimize the risk of long-term complications.
Variables Related to Adherence to Medication
Kirkman et al. (2015) conducted a retrospective study analysis of records obtained
from a pharmacy claims database examining patients, types of medication, and their
prescribers to determine a range of factors that may have influenced adherence to the
prescribed antidiabetic medications. They analyzed more than 200,000 patients records of
individuals who received treatment for diabetes mellitus with oral antidiabetic
medications in 2010 (Kirkman, 2015). The outcome of the study revealed that adherence
to medication was correlated with older age, being a man, higher levels of education,
higher income, method of delivery of medication, and lower copay for medications. Data
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from the study showed that newly diagnosed diabetic patients perceived to be healthy
with no comorbid conditions and who were taking few medications were at greater risk
for nonadherence to antidiabetic medication than the older population with multiple
comorbid conditions (Kirkman, 2015).
In a secondary data analysis of medical records and questionnaires obtained from
1369 diabetic patients, Billimek et al. (2014) found that gender disparities in
nonadherence to medications was responsible for differences observed in lipid
management among individuals living with Type 2 diabetes mellitus. The outcome of the
same study also indicated that the level of nonadherence among women living with
diabetes was associated with the side effects of the medications in question, in addition to
the cost of the medication. They concluded that even though the quality of diabetic care
given to both men and women was comparable, women living with diabetes presented
with poor lipid control more frequently than men living with diabetes mellitus (Billimek
et al., 2014).
Busko (2014) suggested that patients who are diagnosed with Type 2 DM at a
relatively younger ages were more susceptible to diabetic complications as they get older,
due to nonadherence over time. Busko (2014) also suggested that older patients living
with Type 2 diabetes for a longer time coupled with nonadherence have shown to be at an
increased risk of having cardiovascular events such as cardiovascular myopathies, fatal or
nonfatal myocardial infarction, or fatal or nonfatal stroke.
Rosengren et al. (2015) conducted a cohort study involving 33402 participants
who had DM for an average of 20 years and were followed for about 8 years. The

31
outcome of the study revealed that the percentage of participants admitted to the hospital
due to heart failure increased as their age and the duration of diabetes increased. Findings
from the study also showed that uncontrolled hyperglycemia increased the risk of heart
failure and albuminuria among the population. In addition, the study revealed that
participants that had Type 1 diabetes had a four times increased risk of being hospitalized
due to heart failure, when compared with the general population.
Khardori et al. (2015) argued that cardiovascular myopathies among people living
with diabetes is common because it is related in part to nonadherence to antidiabetic
medication which promotes elevated levels of low-density lipoprotein (LDL), low levels
of high-density lipoprotein (HDL), high levels of triglyceride-rich remnant lipoproteins,
thrombotic abnormalities such as high levels of type-1 plasminogen activator inhibitor
(PAI-1), and elevated levels of fibrinogen.
There are obvious disparities in the burden of DM among various populations in
the United States and the world. According to the CDC (2016), African Americans and
Hispanic Americans have been disproportionately affected by diabetes mellitus more so
than any other group in the United States. According to Ogden, Carroll, Kit, and Flegal
(2013) data from the National Health and Nutrition Examination Survey from 2011–2012
show that more than one-third (34.9%) of American adults were obese in 2011–2012.
The survey also showed that obesity was higher among middle-aged adults (39.5%) than
among younger (30.3%) or older (35.4%) adults. There were no disparities between men
and women during same period. However, overall among non-Hispanic Black adults,
56.6% of women were obese compared with 37.1% of men (Ogden et al. 2013). Obesity
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in the United States was more prevalent among non-Hispanic Black (47.8%) followed by
Hispanic (42.5%), non-Hispanic white (32.6%) and less prevalent among non-Hispanic
Asian adults (10.8%) (Ogden et al., 2013). Studies have shown that obesity or being
overweight is a major reason for the alarming prevalence of Type 2 diabetes (WebMD,
2016).
Risk Factors
The risk factors for Type 1 DM include family history (mother, father, or sibling)
with Type 1 diabetes, being of Northern European ancestry, genetic factors such as
positive human leucocyte antigen (HLA-DR3, DR4 and DQ), and environmental factors
(WebMD, 2016; Medscape, 2018). The risk factors for Type 2 diabetes include first
degree relative with DM, obesity or being overweight, impaired glucose tolerance, insulin
resistance, race (African American, Hispanic, and American Indian). Polygenic
components such as high blood pressure, low levels of high-density lipoprotein (HDL),
and high levels of triglycerides, gestational diabetes, sedentary lifestyle, polycystic ovary
syndrome, and advancing age greater than 45 years increases the risk of Type 2 DM
(WebMD, 2016; Medscape, 2018).
According to the Dunn et al. (2014) autoimmune reaction triggered by an
infection such as Coxsackie B virus in a genetically susceptible individual is related to
the etiology of Type 1 diabetes mellitus. The pathogenesis involves lymphocytic
inflammation of the islet of Langerhans (insulitis) that leads to loss of B-cells and fibrosis
of the islets (Kumar et al., 2010). Subsequently, defects in the translation of the insulin
RNA occurs in the ribosomes attached to the rough endoplasmic reticulum (RER). The
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RER is the location where insulin preprohormone is formed. The insulin preprohormone
are subsequently cleaved to produce proinsulin which are further cleaved in the Golgi
apparatus producing insulin and peptide fragments. Inability to synthesize insulin is a
classical pathology associated with Type 1 DM. Insulin synthesis abnormality seen in
Type 1 DM has been associated to genetic abnormality and exposure to environmental
factors such as early childhood infection (Dunn, et al., 2014).
Studies have shown that being overweight or obesity is a risk factor for Type 2
DM because such individuals may have increased insulin resistance (Kumar et al., 2010;
Remington et al., 2010; Khardori et al., 2015). Obesity or being overweight adds an
undue stress to the beta cells of the pancreas. Obese individuals eat more to meet their
bodies energy demands, and overeating stresses the membranous network in the cells
particularly endoplasmic reticulum. Results obtained from studies have shown that when
the endoplasmic reticulum has metabolic product overload it sends a negative feedback,
signaling the cell to dampen the insulin receptors on the cell surface. Sustained
dampening of the insulin receptors due to persistent hyperglycemia translates in to insulin
resistance (Medicinenet, 2018). Type 2 DM develops only in individuals who cannot
adequately compensate for their insulin demand due to their insulin resistance; their
insulin concentration is usually elevated, yet inadequate for tight glycemic control
(Kaplan et al., 2017). Sedentary behaviors and elevated body mass index (BMI) increase
the risks of diabetes, and other chronic diseases (Remington et al., 2010). According to
the WHO (2018) a sedentary lifestyle increases the risk of cardiovascular diseases,
diabetes, and obesity. When physical inactivity combines with nonadherence to
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prescribed antidiabetic medications, the synergistic effect accelerates diabetic
complication among diabetics (Medscape, 2018). Rosengren et al. (2015) suggested that
inadequate glycemic control coupled with sedentary behavior tremendously increased the
risk of cardiac abnormalities among diabetics.
Nonadherence to Medications Among Jamaicans
Result from the 2007/8 Jamaica Health and Life Style Survey (JHLS) of
individuals between the age of 15 to 74 years of age, revealed that about 7.9% of the
population of were living with DM, while 2.8% had impaired fasting glucose also known
as prediabetes (Ferguson et al., 2010). The same study elucidates that comorbid
conditions were common among the target population. About 10.7% of the diabetic
population reported they had one comorbid condition, with 22.3% reporting two
comorbid conditions, while 63.2% reported that they had three or more comorbid
conditions. Only 3.8% of the diabetics reported no comorbid conditions (Wilks et al.,
2009). In addition, data from the survey showed that only 43.9% of diabetics in Jamaica
had tight glycemic control, while 52.6% reported uncontrolled diabetes. This finding
highlights an alarming prevalence of nonadherence to antidiabetic treatment in Jamaica.
Wilks et al. (2009) also reported that results from the 2007/8 JHLS revealed that only
40% of diabetics in Jamaica adhered to their antidiabetic medication, while 60% were
non-adherent.
Common reasons for nonadherence among this target population included
inability to afford medication (7%), sense of feeling better (3.3%), side effects of the
medications (3.0%), hearing other people complain of side effects (1.4%), forgetfulness
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(11%), individuals running out of medication before next appointment (9.0%), and some
diabetics could not bother taking the medications as prescribed (7.0%) (Wilks et al.,
2009). The epidemiology of nonadherence to antidiabetic medication is real and the
alarming incidence of diabetic complications among this target population seem to
correlate with the level of nonadherence to antidiabetic medication therapy.
According to 2007/8 Jamaica Health and Life Style Survey (JHLS) interventions
to prevent nonadherence to antidiabetic medications should be tailored to the specific
needs of each patient since it is obvious that there are different causes of nonadherence
(Hugtenburg, 2013). Preventive measures implemented at the primary level, secondary
level, and tertiary level coupled with many factors working synergistically may be the
antidote to combat nonadherence to antidiabetic medications that translates into diabetic
complications (ADA, 2016). It is a known fact that lack of access to good quality
healthcare may be partly responsible for the alarming rate of nonadherence to antidiabetic
medications in resource poor countries like Jamaica (Rosennberg, 2011). Hence, if the
government of Jamaica is serious about reducing diabetic complications, they must
guarantee access to a well-funded healthcare system for all its citizens.
According to the Ministry of Health (2015) the Jamaican government guarantees
access to public hospitals for all its citizens. However, the healthcare system is grossly
underfunded and severely underserved, hence best medical practices are constantly in
jeopardy. The long wait time discourages patients from attending scheduled visits, and as
a result, many patients run out of antidiabetic medications. Some diabetics stay home,
and only seek care when they start experiencing severe complications (The Jamaican
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Gleaner, 2014). Addressing the challenges that diabetics face while trying to access the
healthcare system is an important preventive measure that cannot be over stated.
Adverse Outcome of Nonadherence to Treatment for Diabetes
Living with either Type 1 or Type 2 diabetes for more than 10 years has been
associated with microvascular and macrovascular complications such as
cardiomyopathies, nephropathy, retinopathies and neuropathic foot ulcer (Busko, 2014).
Atrophy of the pancreas is a diabetic complication that develops because of prolonged
and uncontrolled hyperglycemic state (Kumar et al., 2010).
Cardiovascular Disease
Rosengren et al. (2015) conducted a cohort study with 33,402 participants to
determine the effect of uncontrolled hyperglycemia. The mean age of the patients was 35
years with standard deviation (SD) of 14. 45 years. The participants had diabetes for an
average of 20.1 years [SD 14·5]). The researchers followed participants for about 8 years.
They found that uncontrolled hyperglycemic state translated into increased risk of heart
failure and albuminuria for diabetic patients. Result from the study show that 1062 (3%)
of the participants were admitted to the hospital following heart failure. The percentage
of heart failure increased as the patient advanced in age, and as the duration of diabetes
increased. Participants with Type 1 diabetes had four times increase in the risk of being
hospitalized due to heart failure, when compared with the general population.
Papadakis et al. (2015) argued that cardiovascular myopathies among people
living with diabetes has being associated to insulin resistance or lack of insulin synthesis.
Khardori et al. (2015) indicates that the dysfunction of insulin or lack of insulin synthesis
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coupled with nonadherence to medical treatment amplifies low-density lipoprotein
(LDL), triglyceride-rich remnant lipoproteins, type-1 plasminogen activator inhibitor
(PAI-1), fibrinogen and suppresses high-density lipoprotein (HDL). Khardori et al.
(2015) also reported that microvascular and macrovascular DM complications include
cardiovascular disease, which occurs subsequent to concomitant lipid abnormalities such
as elevated levels of low-density lipoprotein (LDL), decreased levels of high-density
lipoprotein (HDL) and high levels of triglyceride. There are also thrombotic
complications such as high type-1 plasminogen activator inhibitor (PAI-1) and elevated
fibrinogen.
Diabetic Retinopathy
There are two categories of diabetic retinopathy: proliferative and
nonproliferative retinopathies. The nonproliferative retinopathy is the early stage of the
retina involvement and it is characterized by the presence of microaneurysms, dot
hemorrhages, exudates and retinal edema in-addition to macular edema. During the
nonproliferative stage, the integrity of retinal capillaries is compromised resulting in
leaking of proteins, lipids, and red blood cells into the retina. When macular edema
occurs, the functionalities of the visual cells are hampered resulting in the interference
with visual acuity, hence visual impairment. Proliferative retinopathy is more common in
Type 1 diabetes mellitus than Type 2 and involves the growth of new capillaries within
the retina. Proliferative retinopathy develops due to prolonged small vessel occlusion that
cause hypoxia within the retina (Papadakis et al., 2015).
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Diabetic Nephropathy
Diabetic nephropathy is caused by persistent hyperglycemia that cause
hyperfiltration, glycation of metabolites, activation of cytokines, and subsequent renal
injury (Medscape, 2017). Diabetic nephropathy presents like an autoimmune disorder that
has an overlapping pathophysiology of innate immunity and regulatory T-cells activities
in both Type 1 and Type 2 diabetes (Medscape, 2017; Papadakis et al., 2015). Elevated
blood glucose and saturated fatty acids levels create an inflammatory medium, which
results in activation of the innate immune system, thereby activating the nuclear
transcription factors-kappa B (NF-κB), and subsequent release of inflammatory mediators
such as interleukin (IL)–1β and tumor necrosis factor (TNF)–α. This promotes systemic
insulin resistance and β-cell damage due to autoimmune insulitis. Elevated serum glucose
and free fatty acids levels, and IL-1 causes glucotoxicity, lipotoxicity, and IL-1 toxicity,
which culminates in apoptotic β-cell death. Hyperglycemia increases the expression of
transforming growth factor-β (TGF-β) in the glomeruli and of matrix proteins, that are
directly stimulated by this cytokine. TGF-β and vascular endothelial growth factor
(VEGF) are likely to be instrumental in cellular hypertrophy and enhanced collagen
synthesis, thereby inducing the vascular often displayed in diabetic nephropathy
(Medscape, 2017).
Diabetic Neuropathic Foot Ulcer
Diabetic neuropathic foot ulcer is common among diabetic patients with
prolonged duration. According to WebMD (2017) diabetes coupled with nonadherence
increases the risk for neuropathy, and foot ulcer. Lack of tight glycemic control triggers
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an axonal neuropathic process that damage vulnerable nerves particularly the long nerves
Diabetic neuropathy diminishes protective sensation and muscle coordination in the
lower extremities due to denervation of the small muscles of the foot. Diabetic
neuropathic foot ulcers occur due to some mechanical changes in bony conformation
hence altering the architecture of the foot, peripheral neuropathy, and peripheral arterial
disease (Papadakis et al. 2015).
Previous Studies Using the Proposed Methodology
Nonadherence to medical treatment is a problem that has gained enormous
attention. Researchers worldwide have done extensive studies to identify the cause of the
problem and to find solution to nonadherence. Quilliam, Ozbay, Sill and Kogut (2013)
used secondary data obtained from Medstat MarketScan database to measure the
association between adherence to oral antidiabetic drugs and hypoglycemia in persons
with Type 2 diabetes. Medstat MarketScan collected their data through a cross sectional
correlational study design. The investigators included inpatient and outpatient medical
visits records, pharmacy claims records, and patient eligibility ﬁles from 2004 to 2008.
The MarketScan database captured all relevant healthcare information, both inpatient and
outpatient, including medical visits and pharmacy claims.
Quilliam et al. (2013) conducted a retrospective study using a new user design
record to quantify the association between patient adherence to metformin, sulphonylurea
or thiazolidinedione, and the incidence of hypoglycemic events during the same period.
The researchers identified Type 2 diabetics as their target population, and specifically
those managed on metformin, sulphonylurea or thiazolidinedione. They established the
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following inclusion criteria: the patient must be at least 18 years of age, have had two
claims with a Type 2 diabetes diagnosis confirmed by The International Classiﬁcation of
Diseases (ICD-9) code 250.X, 250.X0 or 250.X2, or have had at least one pharmacy
claim for metformin, a sulphonylurea or a thiazolidinedione. The difference between the
study conducted by Quilliam et al. (2013) and my proposal is that I will be exploring
correlations between patient adherence to antidiabetic medication and diabetic
complications, while Quilliam et al. (2013) examined the association of antidiabetic
medications with a major side effect, which is hypoglycemia.
Summary and Conclusion
Studies have shown that tight glucose control reduces diabetic complications
among people with diabetes (Shivashankar et al., 2016; Medscape, 2017). The American
Diabetes Association (ADA) clinical practice guideline presents sufficient evidence that
supports the need for tight glycemic control (ADA, 2016). Diabetes mellitus is a chronic
metabolic disorder that has become global epidemics with enormous social, health, and
economic implications (Shivashankar et al., 2016). The National Diabetes Statistics
report revealed that in 2014, 29.1 million individuals or 9.3% of the American population
were living with diabetes mellitus. The same report suggested that only 21 million of
those living with diabetes were diagnosed, while about 8.1 million people were
undiagnosed (CDC, 2016). WHO (2016) statistical evidence suggested that in 2014 an
estimated 422 million people worldwide were living with diabetes mellitus. It is
anticipated that in the next couple of years, the prevalence rate of diabetes mellitus will
increase to about 530 million if adequate preventive measures and better control or cure
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is not in place. Empirical data had shown that about 50% of the putative diabetics are not
diagnosed until 10 years after onset of the disease or when some diabetic complications
such as retinopathy, diabetic nephropathy or cardiovascular diseases have started
manifesting.
In this quantitative study, I explored whether there were any predictive
relationships between patient adherence to medication for diabetes and severity of
diabetic complications among diabetics in Jamaica. I will use the cross-sectional design
for this study. For this quantitative, correlational study I used data obtained from both in
and out patients who had been diagnosed with either Type 1 or Type 2 diabetes mellitus
in public hospital and private clinics in Jamaica. In chapter 3 I will describe the research
method, purpose of study, research design and rationale, target population, sampling and
sample procedure, procedure used for collection of archived data, procedure I used to
access archived data, instrumentation and operationalization of constructs, ethical
procedures and threats to internal, external and statistical validity.
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Chapter 3: Research Method
Introduction
The purpose of this study was to explore the predictive relationships between
patient nonadherence to antidiabetic medication and HbA1C with diabetic retinopathy,
diabetic nephropathy, cardiovascular diseases, and diabetic neuropathic foot ulcers. In
this chapter, I will describe the research design and rationale. I will define both the
independent and dependent variables, identify my research design and its relevance to the
study and explain time and resource constrains. I will also define my target population,
sampling, sample size, procedure used for collecting archival data, and data analysis
using the SPSS.
Research Designs and Rationale
In this quantitative study, I explored whether there were predictive relationships
between adherence to medication for diabetes and HbA1C with diabetic complications
among people with diabetes in Jamaica. I employed a correlational approach to
investigate the extent to which levels of adherence to antidiabetic medication corresponds
with diabetic complication. The correlational study approach is one of the most
commonly used research designs in health promotion. Creswell (2013) suggested that it
was also the most appropriate design for this study because no control was required in
this kind of study. In addition, I used the correlational design because Kellar and Kelvin
(2013) argued it was useful for predicting the strength and direction of the relationship
between variables. The correlational study design was appropriate for this study because
it enabled me to address the link between nonadherence to antidiabetic medication and
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diabetic complications such as diabetic retinopathy, diabetic nephropathy, cardiovascular
disease, and diabetic neuropathic foot ulcer.
Variables
The independent variables in this study were adherence to recommended
treatment, which was adherence to antidiabetic medication and HbA1C. Adherence to
physicians’ prescribed medication refers to the extent to which a patient takes a given
medication as recommended by a healthcare provider (Ho, Bryson, & Rumsfeld, 2009).
Adherence was determined by interviewer administered Morisky 8-item Adherence Scale
questionnaire. The Morisky 8-item Adherence Scale measures levels of adherence from
0–8 and a patient could score 0 or 1 on each question. A patient was considered adherent
when he/she had cumulative score of 7 – 8 points or nonadherent when the patient had
cumulative score of 0 – 6. Another independent variable used in this study was the
glycated hemoglobin (HbA1C) which Kaplan step2 (2018) refers as a form hemoglobin
that is measured to determine glycemic control within the last previous months. The
dependent variables were diabetic complications such as cardiovascular disease,
retinopathy, nephropathy, and diabetic neuropathic foot ulcers.
Methodology
Population Description
According to Population World (2018), the population of Jamaica in 2017 was
estimated to be 2,990,561, with a predominantly Black population at about 92.1%, mixed
race 6.1%, East Indian 0.8%, other races 1.1%. Approximately 43% of Jamaicans were
single, 38% were married or in a form of union. About 50% of the population had at least
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a high school education. Jamaicans who reported they had tertiary level education were
about 11.3%. About 60% of Jamaicans ages 15-74 years were employed, 45% had full
time paid employment. The JHLS revealed that 40% of Jamaicans were unemployed
during the 2008 survey which was the most current survey of that nature done in Jamaica.
According to Wilks et al. (2008) 33% of Jamaicans have a parent or grandparent
with diabetes and about half (1/2) of the 33% of population adopted lifestyle changes.
Private health insurance is not common in Jamaica, only 19% of Jamaicans had private
health insurance and men were more likely to have the benefit than women. Most
Jamaicans depend on the free healthcare provided by the government in addition to a
National Health Fund (NHF) a complementary pharmacy card solely for purchase of
medications (Wilks et al. 2008).
Data Collection
Data were collected from a dataset I obtained from a General Hospital in Jamaica.
The hospital is in a parish that has a population of 246,322 people and accepts patients
from all parts of the island. The hospital collected the data by a cross-sectional review of
patients’ dockets, an interviewer-administered Morisky 8-item Adherence Scale, and
ICD-9 for chronic disease classifications. Good data quality was ensured by comparing
responses to questionnaires with medical records. The independent variable-adherence to
antidiabetic medications, was coded as levels of adherence (0–8), while the second
independent variable- HbA1c levels, were coded from 1 upwards. Diabetic complications
such as cardiovascular disease, diabetic neuropathic foot ulcer, diabetic retinopathy, and
diabetic nephropathy were coded as: 0 = no complication, 1 = moderate complication, 2 =
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severe complication. Pallant (2010) suggested that the dataset must be checked for error
within each variable for scores that were not within an acceptable range; identified error
must be corrected or deleted before proceeding for analysis.
Sampling and Sampling Procedure
The records came from individuals who presented at outpatient or inpatient at the
General Hospital. I used the G*Power analysis to calculate the minimum sample size
required to detect an effect. The G*Power analysis was used to calculate the optimum
sample size. The results showed that a total of 111 samples would be needed to have an
actual power of 0.9503016, Df of 109, critical t of 1.6589535, and noncentrality
parameter delta of 3.3133098. The effect size | p | is 0.3, alpha error probability is 0.05
and power (1-beta err probability) of 0.95. I purposefully selected records from the
database and the inclusion criteria to include in the data analysis.
Recruitment, Participation and Data Collection
The medical records that I used for this study were for individuals who attended
the public General Hospital as inpatients and outpatients and were diagnosed of diabetes
mellitus Type 1 or Type 2. These individuals were between the ages 18 years to 95 years
when they visited the General Hospital between January 2015 to January 2017. The data
collection was part of the hospital efforts to improve both the intensity and quality of care
for the patients. The hospital keeps medical records in dockets which is used to review
patients whenever they return to the hospital. The Morisky 8-item Adherence Scale was
administered to people with diabetes who visited the hospital for treatment and chose to
participate. The questionnaires were read out to patients who could not read or who
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needed assistance for clarity and understanding of the questions. The hospital also offered
HbA1c test to the patients as part of the data collection and to determine glycemic control
within the previous 3 months.
Validity and reliability of data collection and record keeping
In a quantitative study, the researcher must be concerned with the accuracy and
validity of the data collection techniques. Content validity refers to the degree to which
an adopted measurement technique includes all the essential questions needed to
determine the variable of interest, which in this study was the dependent variable of
medication adherence (Grove & Cipher, 2017). The hospital data collection process
addressed the concerns regarding the validity and reliability of data collected on patient
adherence to medication by developing a standard operating procedure (SOP) that
ensured that only an already validated and standardized instrument would be used in the
data collection related to the independent variable, which was adherence to medication.
The hospital used the Morisky 8-item Medication Adherence Scale (MMAS-8)
questionnaire without any form of modification and it was followed up with HbA1c test
to determine glycemic control. Junior doctors were trained to administer the MMAS-8
questionnaires and to score them according to standard procedure. The staff at the
medical records department were trained to enter the results in the database. Entered data
are reviewed periodically to ensure that data are accurately entered a junior doctor. The
General Hospital used this data to improve quality of care for their patients. As a result, I
assumed that the process and instrument used to collect the data was valid and reliable.
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Data on the dependent variables were collected through reliable and valid hospital
machinery. The HbA1c results were computer generated from blood samples sent to the
hospital laboratory. The instruments the hospital used were adequately calibrated and
duplicate measures were done to ensure good data quality. The computer-generated
results were reviewed by a trained medical technologist before the data were entered into
medical records by the junior doctors. The medical records were periodically reviewed by
a junior doctor to ensure accuracy of test results. Data on the operational dependent
variables of retinopathies, nephropathies, cardiovascular diseases, and neuropathic
diabetic foot ulcers were generated through ICD-9 codes. The ICD-9 codes were
determined by trained junior doctors who extracted the information from the patients’
medical dockets in the hospital and recorded diabetic complications according to severity.
The data were subsequently entered into the database by trained staff in the medical
records. Data were reviewed periodically for accuracy by a trained junior doctor.
Procedure for Gaining Access to Data Set
I obtained permission from the senior medical officer (SMO) of the hospital, to
access archived data that was gained for the secondary analysis in this dissertation. I
received a letter of approval dated October 25, 2017 from the hospital and a copy of
approval is included in Appendix A. I sorted the data and those essential to study were
selected. I removed all forms of personal identifiers to ensure that the identity of the
patients was not compromised. A data set was created from the data obtained, and all the
variables were entered and defined in SPSS. No historical or legal documents were used
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as sources of data; only the archived medical records of individuals from the hospital
were used to gather data related to the variables of interest for this study.
Data Analysis Plan
The focus of my data analysis was to explore associations between independent
variables (patient adherence and HbA1c levels) and dependent variables (diabetic
complications). The plan for data analysis involved establishing and testing the null and
alternative hypothesis and determining the alpha level which is the statistical significance
level. Assumptions of correlational study designs include: (a) the dependent variables
must be continuous, interval, or ratio and the independent variables must be continuous
or dichotomous; (b) the relationship between dependent variable and independent
variables should be approximately linear; (c) the variables must have a relatively normal
distribution; (d) there must not be major outliers among the data; (e) for each value of
independent variables the variance of error terms observed must be constant; and (f) the
independent variables should not be highly correlated (Kellar & Kelvin, 2013). I
ascertained that the data met all assumptions of correlational study design. I also
determined that the variations in the dependent variables is explained by the independent
variables. Kellar and Kelvin (2013) suggested that another integral part of data analysis
plan was to determine the relationship between each independent variable and dependent
variable, and subsequently determine the relative strength of the association of each
independent variable on the dependent variables.
I used the SPSS to run multiple regression analyses to test the null hypotheses for
the research questions. Multiple regression involves the analysis of two or more
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independent variables. I used this procedure to determine whether the independent
variables predicted the outcome variables, which was the dependent variables. I used the
SPSS to perform collinearity diagnostics, homoscedasticity, linearity and normality of all
the variables. I checked these assumptions by inspecting the normal probability plot (p-p)
of the standardized residual and scatterplot. According to Pallant (2010) the normal P-P
plot was used to determine if there were major deviations in normality while the
scatterplot was used to check for linearity of the model and independent error
assumption.
I used the SPSS to run multiple regression analysis that is fundamentally used for
analyzing multiple dependent and independent variables. Kellar and Kelvin (2013)
suggested that the beta coefficients provided information regarding predicted changes in
the outcome with respect to changes in each independent variable when all other factors
are kept constant.
Morisky Medication Adherence Scale
The public hospital used the Morisky 8-item Adherence Scale to collect data on
the independent variable of adherence to medical treatment. A self-reported tool that
was developed by Morisky et al. in 1986, the instrument was termed the Morisky
Medication Adherence Scale (Mercy Clinic, 2018). The Morisky 8-item Adherence Scale
has been validated many times and found to have high internal reliability, high
specificity, and high sensitivity (Okello, Nasasira, Muiru, & Muyingo, 2016). According
to Morisky, Ang, Krausel-Wood, and Ward (2008) the original instrument, which was
used to assess adherence to medication for patients with hypertension, had good internal
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consistency reliability as evidenced by a Cronbach’s alpha equal to .83. The sensitivity or
accuracy for identifying patients with hypertension of was 93% while the specificity or
accuracy for identifying individuals without hypertension was 55%. The construct
validity of the original instrument was supported by results from a confirmatory factor
analysis, which presented a root mean square error of approximation <0.0101.
The psychometric properties of the MMAS- 8 have also been investigated in
several international studies. Cuevas and Penate (2014) validated the psychometric
properties of MMAS-8 with a Spanish sample. Results from their study revealed that the
internal consistency reliability, as measured by Cronbach’s alpha was equal to .75. The
confirmatory factor analysis confirmed on the factor solution showed a GFI of .99, which
was evidence of construct validity. Okello, Nasasira, Muiru, and Muyingo (2016) also
tested the psychometric properties of the MMAS-8 with Ugandan a sample and found
that the internal consistency reliability or Cronbach’s alpha was equal to .65. However,
their test-retest reliability was low with a weighted kappa equal to 0.36 (95% CI0.01,0.73). The overall Kaiser’s measure of sampling adequacy for residuals of 0.72
supported the construct validity through the factor.
Scores on the MMAS-8 are assigned based on the patient’s response to eight scale
questions that is yes or no (Al-Qazaz, Hassali, Shafie, Sulaiman, Sundram, & Morisky,
2010). Questions 1 to 7 on the Morisky-8 Item Adherence Scale focused on establishing
whether a patient takes his/her medications as prescribed, and situations that may
encourage nonadherence to prescribed medications. Responses to questions 1 to 4, and 6
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were measured as yes, equal to zero (0) point, or no, equal to one (1) point each. Question
5 response is coded as yes, equal to one (1) point, and no, is equal to zero (0).
Question 8 was about how often the individuals had difficulty remembering to
take all their medications as prescribed. Responses to question 8 of the Morisky-8 item
medication adherence scale include: (a) never or rarely, which equals four (4) points, (b)
occasionally, which equals three (3) points, (c) sometimes, which equals two (2) points,
(d) usually, which equals one (1) point, or (e) all the time, which was equal to zero (0)
point. Total score points from question 8 was divided by 4 to obtain 1 point or a fraction
of a point. The maximum an individual could score in the Morisky 8-item Adherence
Scale was 8 points (Plakas et al. 2016). I used this exact scale and psychometrics for this
study, no changes were made to the data and I analyzed data as collected by the hospital.
Instrumentation and Operationalization of Variables
The independent variables in this study were patient adherence to antidiabetic
medication and HbA1c levels. Adherence to antidiabetic medication was operationally
defined as consistently taking antidiabetic medications as prescribed by the attending
physician. The Morisky-8 item questionnaire was administered to the individuals, they
were required to respond to 8 questions. Each question in the questionnaire was worth 1
point. The questions were used to determine whether the individuals took their
antidiabetic medication as recommended by their physicians.
Nonadherence or adherence was determined by calculating the number of points
scored by the individual on the Morisky 8-item Adherence Scale. The scores could range
from 0 – 8. For this study if an individual had a high of level adherence score (7 or 8),
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that individual is considered adherent and if an individual had a low level of adherence (6
or less), that individual was considered non-adherent.
The HbA1c level was measured by immunoassay using the venous blood of the
individuals. Levels of HbA1c were used to quantitatively determine an individual’s
glycemic control within the previous 3 months (Papadakis et al., 2015). HbA1c
measurements of 6.5 and below are considered normal and indicative of tight glycemic
control. However, measurements above 6.5 are considered abnormal and indicate poor
glycemic control (Papadakis et al., 2015).
The operational dependent variables were chronic complications that diabetic
patients developed over a period. The operational dependent variables include
retinopathies, nephropathies, cardiovascular diseases, and neuropathic diabetic foot ulcers
(Abass, Fausto & Kumar, 2010). The severity of diabetic complications was measured
using the international classification of chronic disease (ICD- 9). The ICD-9 classifies
chronic conditions from 0 to 2, where 0 = no chronic complication reported, 1 = mild to
moderate chronic complications and 2 = severe chronic complications.
Research Questions and Hypotheses
Research Question 1 (RQ1). How well do patient adherence to antidiabetic
medication and HbA1c levels predict the severity of cardiovascular disease among people
with diabetes in Jamaica after controlling for age and gender?
Null Hypothesis (H01). Patient adherence to antidiabetic medication (Morisky 8item Adherence Scale) and HbA1c levels are not statistically significant predictors of the
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severity of cardiovascular disease among people with diabetes in Jamaica after
controlling for age and gender.
Alternative Hypothesis (Ha1). Patient adherence to antidiabetic medication
(Morisky 8-item Adherence Scale) and HbA1c levels are statistically significant
predictors of the severity of cardiovascular disease among people with diabetes in
Jamaica after controlling for age and gender.
Research Question 2 (RQ2). How well do patient adherence to antidiabetic
medication and HbA1c levels (glycemic control) predict the severity of retinopathy
among people with diabetes in Jamaica after controlling for age and gender?
Null Hypothesis (H02). Patient adherence to antidiabetic medication (Morisky 8item Adherence Scale) and HbA1c levels (glycemic control) are not statistically
significant predictors of the severity of retinopathy among people with diabetes patients
in Jamaica after controlling for age and gender.
Alternative Hypothesis (Ha2). Patient adherence to antidiabetic medication
(Morisky 8-item Adherence Scale) and HbA1c levels are statistically significant
predictors of the severity of retinopathy among people with diabetes in Jamaica after
controlling for age and gender.
Research Question 3 (RQ3). How well do patient adherence to antidiabetic
medication and HbA1c levels (glycemic control) predict the severity of nephropathy
among people with diabetes in Jamaica after controlling for age and gender?
Null Hypothesis (H03). Patient adherence to antidiabetic medication (Morisky 8item Adherence Scale) and HbA1c levels are not statistically significant predictors of the
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severity of nephropathy among people with diabetes in Jamaica after controlling for age
and gender.
Alternative Hypothesis (Ha3). Patient adherence to antidiabetic medication
(Morisky 8-item Adherence Scale) and HbA1c levels are statistically significant
predictors of the severity of nephropathy among people with diabetes in Jamaica after
controlling for age and gender.
Research Question 4 (RQ4). How well do patient adherence to antidiabetic
medication and HbA1c levels predict the severity of neuropathic foot ulcer among
diabetic patients in Jamaica after controlling for age and gender?
Null Hypothesis (H04). Patient adherence to antidiabetic medication (Morisky 8item Adherence Scale) and HbA1c levels are not statistically significant predictors of the
severity of neuropathic foot ulcer among people with diabetes in Jamaica after controlling
for age and gender.
Alternative Hypothesis (Ha4). Patient adherence to antidiabetic medication
(Morisky 8-item Adherence Scale) and HbA1c levels are statistically significant
predictors of the severity of neuropathic foot ulcer among people with diabetes in
Jamaica after controlling for age and gender.
Threats to Validity
Threats to Internal Validity
Assessing the internal and external validity helped to ensure that variations
observed in the dependent variable undoubtedly originate from variations in the
independent variables and not due to confounding factors (Polit & Beck, 2012). To a
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great extent, internal and external validity are dependent on how much control has been
attained in the study while collecting data. The potential threats to internal validity in this
study included inapt collection of patient history, advancing age, clerical error and recall
bias (JHLS, 2008). The archived data analyzed were collected through interview
administered questionnaires and depended on an individuals’ ability to recall events,
hence recall bias, patient history and clerical error may affect the internal validity of the
study. These factors that may be threats to internal validity were addressed by comparing
the information provided in response to the questionnaire with the individual medical
records. Observed discrepancies between patients’ medical records and responses to
questionnaire were either corrected, deleted or rejected.
Threats to external validity
Diabetics with comorbid conditions take numerous medications that could interact
with each other. However, it was difficult to test for effects of drug interactions and its
interference in treatment and hyperglycemic control (Blackburn, Swidrovich & Lemstra,
2013). The inability to measure and control for variables such as levels of physical
activity, healthy diet options, effects of smoking on diabetic complications,
socioeconomic factors, environment and undiagnosed co-morbidities pose threats to
Validity of the results from this study. All these factors could potentiate the
development and severity of all diabetic complications (Universal Teacher, 2016). It is
also essential to mention that a patient’s ability to recall taking medication as prescribed
by the attending physician and not being honest could be a threat to the validity of result
obtained in the study.

56
Ethical Procedures
Agreement to Gain Access to Data
Permission to access archived data was received, following request sent to the
director of non-communicable diseases at the Ministry of Health, Kingston, Jamaica via
email, and to the Senior Medical Officer (SMO) in the general hospital, Jamaica. Raw
data contained all patient identifiers, which were cleaned and information relevant to the
study extracted. Data was coded to eliminate patient identifiers, and risk of exposure, and
was subsequently analyzed following receipt of approval from both Walden University
and the general hospital.
Treatment of Archival Data
The archived data were safeguarded and will not be divulged to others. Care was
taken to prevent unwanted access to archived data, as researcher is ethically obligated to
ensure that the use of the data and or the dissemination of study outcome will not do any
harm to the system that provided the data, or to the people that accessed the health care
system. Therefore, archived data were used solely for this study, and if needed for future
studies, researcher is obligated to notify the hospital system. The data obtained will not
be shared with any other person or organization. Individual patient informed consents
were not needed for this study since it was only secondary data analysis. No treatment or
invasive test done was done during for this study. At the end of this study, archived data
used for the study will be appropriately destroyed.
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Summary
Chapter 3 outlined description of the study design, sample character and sample
methods, instrumentation, data analysis and ethical procedures. Rationale was presented
for using correlational study design instead of other study designs. The data collection
process used by the hospital system in Jamaica was also described. Adequate
demographics particularly age and gender which were important for this study were
obtained from individuals. A cross-sectional patient medical record review was done
along with interviewer administered Morisky 8-item Adherence Scale used to measure an
individual’s level of medication adherence and HbA1c measured by ELISA method used
to determine glycemic control over a 3 months period. The level of adherence and
glycemic control/HbA1c are the independent variables while diabetic retinopathy,
diabetic nephropathy, cardiovascular disease, and diabetic neuropathic foot ulcer are the
dependent variables. A correlational study approach was used to investigate the extent to
which levels of adherence to antidiabetic medication corresponds with diabetic
complications. Internal and external validity ensured that variations that were observed
among dependent variables originated from variations within the independent variables
and not because of confounding factors (Polit & Beck, 2012).
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Chapter 4: Results
Introduction
The purpose of this study was to explore the predictive relationships between
patient adherence to antidiabetic medications, patient HbA1c levels, and diabetic
complications among Jamaicans. The general question that guided this research was:
How well do the independent variables (patient adherence to antidiabetic medication and
HbA1c levels) predict the severity of diabetic complications (retinopathy, nephropathy,
cardiovascular disease, and neuropathic foot ulcer) among people with diabetes patients
in Jamaica after controlling for age and gender?
Research Question 1 (RQ1). How well do patient adherence to antidiabetic
medication and HbA1c levels predict the severity of cardiovascular disease among people
with diabetes in Jamaica after controlling for age and gender?
Null Hypothesis (H01). Patient adherence to antidiabetic medication (Morisky 8item Adherence Scale) and HbA1c levels are not statistically significant predictors of the
severity of cardiovascular disease among people with diabetes in Jamaica after
controlling for age and gender.
Alternative Hypothesis (Ha1). Patient adherence to antidiabetic medication
(Morisky 8-item Adherence Scale) and HbA1c levels are statistically significant
predictors of the severity of cardiovascular disease among people with diabetes in
Jamaica after controlling for age and gender.
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Research Question 2 (RQ2). How well do patient adherence to antidiabetic
medication and HbA1c levels (glycemic control) predict the severity of retinopathy
among people with diabetes in Jamaica after controlling for age and gender?
Null Hypothesis (H02). Patient adherence to antidiabetic medication (Morisky 8item Adherence Scale) and HbA1c levels (glycemic control) are not statistically
significant predictors of the severity of retinopathy among people with diabetes patients
in Jamaica after controlling for age and gender.
Alternative Hypothesis (Ha2). Patient adherence to antidiabetic medication
(Morisky 8-item Adherence Scale) and HbA1c levels are statistically significant
predictors of the severity of retinopathy among people with diabetes in Jamaica after
controlling for age and gender.
Research Question 3 (RQ3). How well do patient adherence to antidiabetic
medication and HbA1c levels (glycemic control) predict the severity of nephropathy
among people with diabetes in Jamaica after controlling for age and gender?
Null Hypothesis (H03). Patient adherence to antidiabetic medication (Morisky 8item Adherence Scale) and HbA1c levels are not statistically significant predictors of the
severity of nephropathy among people with diabetes in Jamaica after controlling for age
and gender.
Alternative Hypothesis (Ha3). Patient adherence to antidiabetic medication
(Morisky 8-item Adherence Scale) and HbA1c levels are statistically significant
predictors of the severity of nephropathy among people with diabetes in Jamaica after
controlling for age and gender.
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Research Question 4 (RQ4). How well do patient adherence to antidiabetic
medication and HbA1c levels predict the severity of neuropathic foot ulcer among
diabetic patients in Jamaica after controlling for age and gender?
Null Hypothesis (H04). Patient adherence to antidiabetic medication (Morisky 8item Adherence Scale) and HbA1c levels are not statistically significant predictors of the
severity of neuropathic foot ulcer among people with diabetes in Jamaica after controlling
for age and gender.
Alternative Hypothesis (Ha4). Patient adherence to antidiabetic medication
(Morisky 8-item Adherence Scale) and HbA1c levels are statistically significant
predictors of the severity of neuropathic foot ulcer among people with diabetes in
Jamaica after controlling for age and gender.
In this chapter I have included information regarding the time frame the hospital
used for data collection and their recruitment process as well as the response rates. I
present any discrepancies in data collection or deviations from data collection plan
presented in the previous chapter. I also present the descriptive and demographic
characteristics of the sample. It was essential for me to describe if the sample was a true
representation of the target population or the Jamaican population at large. The data were
analyzed using multiple regression analysis on SPSS platform.
Data collection
The data I used in this study was obtained from a public hospital that has an
ongoing data collection process for information related to chronic diseases and infectious
diseases. The archived data used in this study was collected through the Morisky 8-item
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Adherence Scale questionnaires were issued to patients between January 2015 to
December 2016 to a total of 119 individuals. These were individuals who visited the
public hospital within that period and met the participation criteria. The Morisky 8-item
Adherence Scale and ICD-9 chronic disease classification questionnaire as well as testing
for HbA1c levels by ELISA method were all administered by trained staff. The
interviewers were adequately trained and certified by the hospital before they were
assigned to the patients. Instruments used were adequately calibrated and duplicate
measures were done according to the standard operating procedure (SOP).
Results
Preparing Data for Analysis
Data cleaning is a major part of data preparation that is done before analysis; two
types of data cleaning were done before data analysis: the possible code cleaning and
contingency cleaning. Kellar and Kelvin (2013) argued that possible code cleaning
involved finding and eliminating errors in the data matrix hence ensuring that only
answer choices for each question was entered in the associated field. Crossman (2017)
suggested that during the contingency cleaning I ensured that only those cases that should
have data on a variable do indeed had such data hence, if a number outside the predefined
possibilities were entered an error message appeared. I removed all personal identifiers
from the data set analysis.
Descriptive statistics
The independent variables were the level of adherence to antidiabetic medications
and HbA1c values, the dependent variables included cardiovascular disease, diabetic
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retinopathy, diabetic nephropathy, and diabetic neuropathic foot ulcer. Table 1 shows
summary of the descriptive variables for each of the variables included in the data
analysis. A total of 119 individual medical records were used, of which 42% were male,
and 58% were female as also shown in Figure 1.
Levels of adherence to antidiabetic medication was measured with Morisky 8item Adherence Scale. The mean adherence level was 6.11 with a standard deviation of
.35 as shown in Table 1. The chart in Figure 1A reveals that 34.4% of patients had high
levels of adherence (adherent), and 65.6% had low level of adherence (non-adherent) to
prescribed diabetic treatment. The HbA1c level was used to determine glycemic control
within the previous 3 months. The results revealed that the average level of HbA1c was
8.84, which implied that the overall targeted population did not adequately control their
glucose levels within the period in question as shown in Table 1. The standard deviation
of HbA1c levels was 2.83, indicating that some people with diabetes in this target
population had HbA1c as high as 11.67 while others had HbA1c as low as 6.01. As
shown in Figure 1B, only 25.2% of the individual had normal HbA1c (4.62 – 6.50) while
74.8% had abnormal levels of HbA1c (6.60 – 18.03).
Figure 2 shows that 59.7% of the diabetic population did not report, and were not
diagnosed with cardiovascular disease, while 15.1% had mild cardiovascular disease, and
25.2% had severe cardiovascular disease. Data in Table 1 show that the mean for the
severity of cardiovascular disease was 0.66, with a standard deviation of 0.86 which
indicated that the frequency of cardiovascular disease among the targeted population was

63
as high as 1.52 in some individuals, while cardiovascular disease was not reported or
diagnosed in some individuals within the population.
Figure 2 also shows that 72.3% of the people with diabetes did not have diabetic
retinopathy, 21% had mild retinopathy while 6.7% had severe diabetic retinopathy. The
average score for severity of diabetic retinopathy was 0.34 with standard deviation of
0.603 which also implies that the frequency of diabetic retinopathy among individuals
was as high as 0.943, while others did not report the disease. Table 1 and figure 3 show
that 83.2% of the patients were not diagnosed with diabetic nephropathy, 8.4% had mild
nephropathy while another 8.4% had severe diabetic nephropathy. The mean severity of
diabetic nephropathy was 0.25 with standard deviation of 0.600 which indicates that the
frequency nephropathy was as high as 0.85 among some individuals while others did not
have the disease at all. As shown in Table 1 and Figure 2, 77.3% of the patients were not
diagnosed with diabetic neuropathic foot ulcer, 9.2% had mild diabetic neuropathic foot
ulcer while 13.4% had severe diabetic neuropathic foot ulcer. The mean severity of
diabetic neuropathic foot ulcer was 0.36 with a standard deviation of 0.710 which means
that the frequency of neuropathic foot ulcer was as high as 0.85 among some people with
diabetes while some others did not report the complication.
Table 1
Summary of Descriptive Statistics of Variables
Variables
Gender

Adherence
Level

Male
Female
3-6
7-8

Frequency
50
69
78
41

Percent Mean
42
58
65.6
34.4

6.11

Std. Deviation

N
119

1.352
119
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HbA1c Levels 4.62 - 6.50
(Glycemic cont.) 6.60 – 18.03

25.2
74.8

25.2
74.8

No Cardiovascular Disease
Mild Cardiovascular Disease
Severe Cardiovascular Disease

71
18
30

59.7
15.1
25.2

.66

No Retinopathy
Mild Diabetic Retinopathy
Severe Diabetic retinopathy

86
25
8

72.3
21.0
6.7

.34

No Nephropathy
Mild Diabetic Nephropathy
Severe Diabetic Nephropathy

99
10
10

83.2
8.4
8.4

.25

No Neuropathic Foot Ulcer
92
Mild Diabetic Neuropathic Foot Ulcer 11
Severe Diabetic Neuro Foot Ulcer
16

77.3
9.2
13.4

119
.858
119
.603
119
.600
119
.36

.710
119
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Figure 1A. Bar charts of gender and levels of adherence.

Figure 1B. Bar chart of HbA1c Levels.
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Figure 2. Bar chart of Cardiovascular disease and diabetic retinopathy.

Figure 3. Bar chart of diabetic neuropathic foot ulcer and diabetic nephropathy.

Testing Statistical Assumptions
The statistical assumptions of multiple regression include independence of
variables (adherence level and HbA1c levels) must have a linear relationship with the
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dependent variables (cardiovascular disease, retinopathy, nephropathy, and neuropathic
foot ulcer). The residuals must be normally distributed, the independent variables must
not be highly correlated with each other and the variance of error terms must be similar
across the values of the independent variables (Kellar & Kelvin, 2013). Figures 4 to 12
below show scatter plots for each of the independent variables versus diabetic
complications (dependent variables). The expected cumulative probability of the normal
p-p plot is on the y-axis while the observed cumulative probability values are on the xaxis. Normal P-P plot of regression standardized residual suggest that the dependent
variables are approximately normally distributed for each independent variable.
I used the scatter plots to check for homoscedasticity, linearity of the model,
normality and independent error assumption. The plots show a distribution of data that
are relatively evenly distributed around the zero point. The figures also show that there
are no major deviations or outliers observed in the randomly displayed data. The scatter
plot regression standardized residuals are on the y-axis while the regression standardized
predicted values are on the x-axis. The scatter plots show that the residuals and the
variance of the residuals are the same for all predicted values. This observation indicates
that the assumptions of homoscedasticity, linearity of the model and independent error
are met (Kellar & Kelvin, 2013).
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Figure 4. Scatterplot of Independent Variables Vs Cardiovascular Disease.

Figure 5. Normal P-P Plot of Independent Variables Vs Cardiovascular Disease.

Figure 6. Scatterplot of Independent Variables Vs Diabetic Retinopathy.
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Figure 7. Normal P-P Plot of Independent Variable Vs Diabetic Retinopathy.

Figure 8. Normal P-P Plot of Independent Variables Vs Diabetic Nephropathy.
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Figure 10. Scatterplot of Independent Variables Vs Diabetic Nephropathy.

Figure 11. Normal P-P Plot of Independent Variables Vs Diabetic Neuropathic Foot
Ulcer.
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Figure 12. Scatterplot of Independent Variables Vs Diabetic Neuropathic Foot Ulcer.

Inferential statistical analysis
Using statistical inference, I have made propositions regarding my target
population, via the data collected from diabetic patients that attended the public hospital
during the period. I have proposed my hypothesis about the target population from which
I drew inferences. Multiple regression analysis model was used to generate data that
inferred statistical properties that included testing hypotheses and descending estimates.
My targeted population is assumed to be sampled from a larger population (Konishi &
Kitagawa, 2008). Data analyzed included independent variables (adherence to treatment
and HbA1c levels) and dependent variables (cardiovascular diseases, diabetic
retinopathy, diabetic nephropathy and diabetic neuropathic foot ulcer).
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Cardiovascular Disease
RQ1: How well do patient adherence to antidiabetic medication and HbA1c levels
predict the severity of cardiovascular disease among people with diabetes in Jamaica after
controlling for age and gender?
H01: Patient adherence to antidiabetic medication (Morisky 8-item Adherence
Scale) and HbA1c levels are not statistically significant predictors of the severity of
cardiovascular disease among people with diabetes in Jamaica after controlling for age
and gender.
Ha1: Patient adherence to antidiabetic medication (Morisky 8-item Adherence
Scale) and HbA1c levels are statistically significant predictors of the severity of
cardiovascular disease among people with diabetes in Jamaica after controlling for age
and gender.
I conducted multiple linear regression analysis to test the null hypothesis for
Research Question1. Results from the ANOVA test produced results for two regressions
models. The data revealed that variables in both regression models significantly predicted
the severity of cardiovascular disease. Model 1 contained age and gender as the
covariates that were used to test for the effect of interactions of the independent variables
on the dependent variables (severity of cardiovascular disease) variable, F (2,116) =
18.26, p = .000. Model 2 contained patient adherence scores and HbA1c levels as
independent variables, age and gender as covariates, and severity of cardiovascular
disease as the dependent variables, F (4,114) = 18.00, p = .000.
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Table: 2.

ANOVA Summary Table of cardiovascular disease vs independent variables
Model

Sum of
Squares

1

2

Df

Mean Square

Regression

20.763

2

10.382

Residual

66.111

116

Total

86.874

118

Regression

33.627

4

8.407

Residual

53.247

114

.467

Total

86.874

118

F

Sig.

18.216

.000b

17.999

.000c

.570

a. Dependent Variable: Cardiovascular Disease
b. b. Predictors: (Constant), Age, Gender
c. c. Predictors: (Constant), Age, Gender, Adherence to treatment, HbA1c levels
(Glycemic Control)
The regression model summary is presented in Table 2. Data in this table were
used to determine how much each variable contributed to the variance in severity of
cardiovascular disease. Data in Table 3 showed that in Model 1, age accounted for
20.763% [R2=.24, R2adj=.226, F (2,116) = 18.216, p = .000] of the variance in the severity
of cardiovascular disease. Adding patient adherence scores and HbA1C levels in Model 2
resulted in a statistically significant change in the model, R=.622, R2adj=.387, F (2,114) =
13.771, p = .000] value. Results showed that the R2adj value by increase by .148, which
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indicated a 14.8% change in the amount of variance accounted for by the regression
model. Data in table 3 showed that adding patient adherence scores and HbA1C levels
increased the amount of variance accounted for in the severity of cardiovascular disease
to 36.6% and 22.6% respectively. Both independent variables made statistically
significant contributions to the change in variance in cardiovascular disease.
Table 3.
Regression Model Summary of cardiovascular disease
Model

1
2

R R Square Adj. R Std. Error
Change Statistics
Square
of the R Square
Sig. F
Estimate Change F Change df1 df12 Change
.489a
.622b

.239
.387

.226
.366

.755
.683

.239
.148

18.216
13.771

2
2

116
114

.000
.000

Beta coefficients were used to determine which variables in the regression model
predicted the severity of cardiovascular disease. Results for the unstandardized beta
coefficients in Table 4 showed that only age and HbA1c (glycemic control) were
statistically significant contributors to the severity of cardiovascular disease. The data
showed that each unit of change in age resulted in a change of .026 units in the severity
of cardiovascular disease. Results also revealed that each unit of change in HbA1C levels
resulted in .114 units of change in the severity of cardiovascular disease. The overall
regression equation is presented below:
.203(gender) + .021(age groups) - .022 (patient adherence to treatment) + .114
(glycemic control/HbA1C) = severity of cardiovascular disease
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Table 4.
Regression Coefficients of cardiovascular disease
Model

1

(Constant)
Gender
Age

Unstandardized
Standardized
Coefficients
Coefficients
B
Std. Error
Beta
-1.138 .348
.107
.141
.062
.026
.004
.481

t

Sig.

-3.273
.763
5.921

.001
.447
.000

-2.632
1.576
5.047
-.339
3.700

.010
.118
.000
.735
.000

2
(Constant)
Gender
Age
adherence to medication
Glycemic Control/HbA1c

-1.837
.203
.021
-.022
.114

.698
.129
.004
.063
.031

.118
.383
-.034
.376

Diabetic Retinopathy
RQ2: How well do patient adherence to antidiabetic medication and glycemic
control/HbA1c levels predict the severity of diabetic retinopathy among diabetic patients
in Jamaica after controlling for age and gender?
H20: Patient adherence to antidiabetic medication (Morisky 8-item Adherence
Scale) and Glycemic control/HbA1c levels are not statistically significant predictors of
the severity of diabetic retinopathy among diabetic patients in Jamaica after controlling
for age and gender.
H2A: Patient adherence to antidiabetic medication (Morisky 8-item Adherence
Scale) and Glycemic control/HbA1c levels are statistically significant predictors of the
severity of diabetic retinopathy among diabetic patients in Jamaica after controlling for
age and gender.
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Multiple linear regression analysis was conducted to test the null hypothesis for
Research Question 2. Result from the ANOVA test produced results for two regressions
models. The data revealed that variables in both regression models significantly predicted
the severity of diabetic retinopathy. As shown in table 5 model 1 contained age and
gender (covariates) as independent variables and the severity of diabetic retinopathy as
the dependent variable, F (2,116) = 4.937, p = .009. Model 2 contained patient adherence
scores and glycemic control/HbA1c levels as independent variables, age and gender as
covariates, and severity of diabetic retinopathy as the dependent variables, F (4,114) =
3.761, p = .007.
Table: 5.
ANOVA Summary Table of Diabetic Retinopathy
Model

1

Regression
Residual
Total

2

Regression
Residual
Total

Sum of
Squares

Df

3.363
39.511
42.874

2
116
118
4
114
118

4.998
37.875
42.874

Mean Square

F

Sig.

1.682
.341

4.937

.009b

1.250
.332

3.761

.007c

a. Dependent Variable: Diabetic Retinopathy
b. Predictors: (Constant), Age, Gender
c. Predictors: (Constant), Age, Gender, Adherence or Nonadherence, Glycemic Control

The regression model summary is presented in Table 6. Data in this table were
used to determine how much each variable contributed to the variance in severity of
diabetic retinopathy. Data in Table 9 showed that in Model 1, age and gender accounted
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for 6.3% [R2=.078, R2adj=.063, F(2,116)=4.937, p = .009] of the variance in the severity
of diabetic retinopathy. When patients’ adherence scores and glycemic/HbA1C levels
were added in Model 2 they resulted in a statistically significant change in the model,
R2=.341, R2adj=.086, F(2,114)=2.461, p = .09] value. Result show that the R2adj value
increased by .038, which indicated a 3.8% change in the amount of variance accounted
for by the regression model. Data in table 9 showed that adding patient adherence scores
and glycemic control/HbA1C levels increased significantly the amount of variance
accounted for in the severity of diabetic retinopathy accounted for by regression model to
8.6%.
Table 6.
Regression Model Summary of Diabetic Retinopathy
Model

R

R
Square

Adjusted
R Square

Std.
of the
Estimate

1

.280a .078

.063

.584

Change Statistics
R Square
Change F Change df1 df2 Sig. F
Change
.078
4.937
2 116
.009

2

.341b .117

.086

.576

.038

2.461

2

114

.090

Beta coefficients were used to determine which variables in the regression model
predicted the severity of diabetic retinopathy. Results for the standardized beta
coefficients in Table 7 showed that only age group was statistically significant
contributors to the severity of diabetic retinopathy as measured. The data show that each
unit of change in age resulted in a change of .009 units in the severity of diabetic
retinopathy. Both HbA1c and adherence to treatment were statistically insignificant to the
severity of retinopathy. The overall regression equation is presented below:
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-.047(gender) + .009(age groups) + .009 (patient adherence to treatment) + .046
(glycemic control/HbA1C = severity of diabetic retinopathy
Table 7.
Regression Coefficients of Diabetic Retinopathy
Model

Unstandardized
Coefficients
B
Std. Error
1
(Constant)
-.178
.269
Gender
-.084
.109
Age
.011
.003
2
(Constant)
-.586
.589
Gender
-.047
.109
Age
.009
.003
Adherence
.009
.053
HbA1c
.046
.026
Levels
Dependent variable retinopathy

Standardized
Coefficients
Beta
-.069
.276
-.996
-.039
.228
.021
.216

T
Sig.
-.662
.509
-.776
.439
3.091
.002
.322
-.432
.667
2.504
.014
.172
.863
1.772 .079

Diabetic Nephropathy
RQ3: How well do patient adherence to antidiabetic medication and glycemic
control/HbA1c levels predict the severity of nephropathy among people with diabetes in
Jamaica after controlling for age and gender?
H30: Patient adherence to antidiabetic medication (Morisky 8-item Adherence
Scale) and Glycemic control/HbA1c levels are not statistically significant predictors of
the severity of nephropathy among people with diabetes in Jamaica after controlling for
age and gender.
H3A: Patient adherence to antidiabetic medication (Morisky 8-item Adherence
Scale) and HbA1c levels are statistically significant predictors of the severity of
nephropathy among people with diabetes in Jamaica after controlling for age and gender.
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The null hypothesis was tested by conducting multiple linear regression analysis
for Research Question 3. Result from the ANOVA test produced results for two
regressions models. The data revealed that variables in both regression models
significantly predicted the severity of diabetic nephropathy. Model 1 contained age and
gender covariates and the severity of disease diabetic nephropathy as the dependent
variable, F (3,470) = 5.166, p = .007. Model 2 contained patient adherence scores and
glycemic control/HbA1c levels as independent variables, age and gender as covariates,
and severity of diabetic nephropathy as the dependent variables, F (7,871) = 6.490 p =
.000.
Table: 8.
ANOVA Summary Table of diabetic nephropathy
Model
1

Regression
Residual
Total

Sum of
Squares
3.470
38.697
42.437

Df
2
116
118

Mean
Square
1.735
.336

F

Sig.

5.166

.007b

Regression
7.871
4
1.968
6.490 .000c
Residual
34.566
114
.303
Total
42.437
118
a. Dependent Variable: Diabetic Nephropathy
b. Predictors: (Constant), Age, Gender
c. Predictors: (Constant), Age, Gender, Adherence or Nonadherence,
Glycemic Control/HbA1c
2

The regression model summary is presented in Table 9. Data in this table were
used to determine how much each variable contributed to the variance in severity of
diabetic nephropathy. Data in Table 6 showed that in Model 1, age and gender accounted
for 6.6% [R2=.082, R2adj=.066, F(2,116)=5.166, p = .007] of the variance in the severity
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of diabetic nephropathy. Adding patient adherence scores and HbA1C levels in Model 2
resulted in a statistically significant change in the model, R2=.185, R2adj=.157,
F(2,114)=7.257, p = .001] value. Results show that the R2adj value increased by .104,
which indicated a 10.4% change in the amount of variance accounted for by the
regression model. Data in table 6 showed that adding patient adherence scores and
HbA1C levels increased the amount of variance accounted for in the severity of diabetic
nephropathy to 15.7%.
Table 9.
Regression Model Summary of Diabetic Nephropathy
Model R R Square Adj. R
Square

1
2

.286a .082
.431b .185

.066
.157

Std. Error
of the
Estimate

.580
.551

__Change Statistics______
R Square
Change

Sig. F
F Change df1 df12 Change

.082
.104

5.166
7.257

2
2

116
114

.007
.001

Beta coefficients were used to determine which variables in the regression model
predicted the severity of diabetic nephropathy. Results for the standardized beta
coefficients in Table 10 showed that only age and glycemic control/HbA1C were
statistically significant contributors to the severity of diabetic nephropathy. The data
show that each unit of change in age resulted in a change of .008 units in the severity of
diabetic nephropathy. Results also revealed that each unit of change in glycemic
control/HbA1C levels resulted in .086 units of change in the severity of diabetic
nephropathy. The overall regression equation is presented below:
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-.04(gender) + .008(age groups) + .055 (patient adherence to treatment) + .086
(glycemic control/HbA1C = severity of diabetic nephropathy
Table 10.
Regression Coefficients of Diabetic Nephropathy
Model

Unstandardized
Coefficients
B
Std. Error
1
Constant
-.238
.267
Gender
-.106
.108
Age
.011
.003
2 Constant
-1.262
.562
Gender
-.040
.104
Age
.008
.003
Adherence level .055
.051
HbA1c /
.086
.025
Glycemic control

Standardized
Coefficients
Beta
-.088
.278
-.033
.205
.123
.404

T
-.892
-.981
3.121
-2.243
-.382
2.349
1.070
3.449

Sig.
.374
.329
.002
.027
.703
.021
.287
.001

Diabetic Neuropathic Foot Ulcer
RQ4: How well do patients adherence to antidiabetic medication and glycemic
control/HbA1c levels predict the severity of neuropathic foot ulcer among people with
diabetes in Jamaica after controlling for age and gender?
H40: Patient adherence to antidiabetic medication (Morisky 8-item Adherence
Scale) and Glycemic control/HbA1c levels are not statistically significant predictors of
the severity of neuropathic foot ulcer among people with diabetes in Jamaica after
controlling for age and gender.
H4A: Patient adherence to antidiabetic medication (Morisky 8-item Adherence
Scale) and glycemic control/HbA1c levels are statistically significant predictors of the
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severity of neuropathic foot ulcer among people with diabetes in Jamaica after controlling
for age and gender.
The null hypothesis for Research Question 4 was tested by conducting multiple
linear regression analysis. The ANOVA test produced results for two regressions models.
The data revealed that variables in both regression models significantly predicted the
severity of diabetic neuropathic foot ulcer. Model 1 contained age and gender
(covariates) as independent variables and the severity of diabetic neuropathic foot ulcer
as the dependent variable, F (2,116) = 3.738, p = .027. Model 2 contained patient
adherence scores and glycemic control/HbA1c levels as independent variables, age and
gender as covariates, and severity of diabetic neuropathic foot ulcer as the dependent
variables, F (4,114) = 5.655, p = .000.
Table: 11.
ANOVA Summary Table of Diabetic Neuropathic Foot Ulcer
Model
1

Sum of
Squares
Regression
3.600
Residual
55.862
Total
59.462

Df
2
116
118

Mean Square
1.800
.482

F
3.738

Sig.
.027b

Regression
9.845
4
2.461
5.655 .000c
Residual
49.618
114
.435
Total
59.462
118
a. Dependent Variable: Diabetic Foot Ulcer
b. Predictors: (Constant), Age, Gender
c. Predictors: (Constant), Age, Gender, Adherence or Nonadherence, Glycemic
Control/HbA1c
2
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The regression model summary is presented in Table 12. Data in this table were
used to determine how much each variable contributed to the variance in severity of
neuropathic foot ulcer. Data in Table 12 showed that in Model 1, age and gender
accounted for 4.4% [R2=.061, R2adj=.044, F(2,116)=3.738, p = .027] of the variance in
the severity of diabetic neuropathic foot ulcer. Adding patient adherence scores and
glycemic control/HbA1C levels in Model 2 resulted in a statistically significant change in
the model, R2=.105, R2adj=.136, F(2,114)=7.174, p = .001] value. Results show that the
R2adj value by increase by .105, which indicated a 10.5% change in the amount of
variance accounted for by the regression model. Data in table 12 also showed that adding
patient adherence scores and glycemic control/HbA1C levels increased the amount of
variance accounted for in the severity of diabetic neuropathic foot ulcer to 13.6%.
Table 12.
Regression Model Summary Diabetic Neuropathic Foot Ulcer
Change Statistics

Model
1
2

R
Square
.246a
.407b

Std. Error R
Adjusted of the
Square
F
R Square Estimate Change Change
.061
.044 .694 .061 3.738
.166
.136 .660 .105 7.174

df1
2
2

Sig. F
df2 change
116
.027
114
.001

The beta coefficients were used to determine which variables in the regression
model predicted the severity of diabetic neuropathic foot ulcer. Results for the
standardized beta coefficients in Table 12 showed that only glycemic control/HbA1c was
statistically significant contributor to the severity of diabetic neuropathic foot ulcer after
controlling for age and gender. Results in Table 13 revealed that each unit of change in
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glycemic control/HbA1C levels resulted in .084 units of change in the severity of diabetic
neuropathic foot ulcer. The overall regression equation is presented below:
-.021(gender) + .007(age groups) - .003 (patient adherence to treatment) + .084
(glycemic control/HbA1C = severity of diabetic neuropathic foot ulcer
Table 13.
Regression Coefficients of Neuropathic Foot Ulcer

Model
1
(Constant)
Gender
Age

Unstandardized
Coefficients
B
Std. Error
-.173
.320
-.091
.129
.011
.004

Standardized
Coefficients
Beta

(Constant)
-.777
. 674
Gender
-.021
.125
Age
.007
.004
Adherence
-.003
.061
HbA1c
.084
.030
Dependent Variable: Diabetic neuropathic Foot Ulcer

-.063
.242

2

-.015
.161
-.005
.333

T
-.540
-.701
2.685

Sig.
.590
.484
.008

-1.153
-.170
1.814
-.044
2.809

.251
.865
.072
.965
.006

Summary of Answers to Research Questions
The independent variables are the HbA1C/glycemic control and adherence levels
determined by using Morisky 8-item scale while the dependent variables are
cardiovascular disease, diabetic retinopathy, diabetic nephropathy, and diabetic
neuropathic foot ulcer. The independent variables HbA1c and adherence levels)
correlates with cardiovascular disease. Neither HbA1c nor adherence level correlated
diabetic retinopathy, however, HbA1c correlated with both diabetic nephropathy and
diabetic foot ulcers after controlling for age and gender.
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The result indicates that the null hypothesis which suggests that there is no
statistical predictive relationship between the independent variables (adherence level and
glycemic control /HbA1c) and the dependent variable (cardiovascular disease, diabetic
nephropathy and diabetic neuropathic foot ulcer) should be rejected. The P-P plot of
regression standardized residual were normal suggesting there were no major deviations
from normality. The scatter plots also show even distribution of data above and below the
zero axis without obvious outliers.
In chapter 5, I will present a detailed interpretation of the findings of this study,
which will be kept within the limits and scope of the study. I will also discuss the
limitations of this study and the implications for social change. The methodological,
theoretical, and empirical implications of this study will also be described, and strong
recommendations and conclusion provided.
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Chapter 5: Discussion, Conclusions, and Recommendations
Introduction
The purpose of this quantitative, correlational study was to explore the
relationship between levels of adherence to antidiabetic medications, HbA1c levels, and
diabetic complications (cardiovascular disease, diabetic retinopathy, diabetic
nephropathy, diabetic neuropathic foot ulcer). This study revealed that levels of
adherence to antidiabetic medication negatively correlates with diabetic complications
while HbA1c levels positively correlate with diabetic complications. Nonadherence to
medications prescribed by a physician is a complex behavioral issue that in most cases
triggers multidimensional problems. According to Hugtenburg et al. (2013) there are
numerous factors that are associated with nonadherence. These factors include when a
patient refuses to fill or refill his/her prescriptions in a timely manner, consequently may
not commence treatment at all or may not continue treatment as scheduled by the
attending physician. Nonadherence also includes when a patient uses more prescribed
medications than directed, less medications than prescribed, or deviates from scheduled
time of medication administration (Hugtenburg et al., 2013). Results from several studies
have shown that nonadherence to antidiabetic medications compromises a patient’s
ability and opportunity to achieve tight glycemic control, hence patients may face acute
and chronic diabetic complications (Costa et al., 2015; Khan et al., 2012; Kumar et al.,
2010).
Ferguson, Tulloch-Reid, and Wilks (2010) affirmed that there are only a few
published studies regarding patient adherence to medication and diabetic complications in
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Jamaica and the Caribbean region. Hence, I have explored the predictive relationships
between patient adherence to antidiabetic medications and diabetic complications among
Jamaicans. It is my expectation that this study will have positive impact among the target
population and will add to the existing knowledge. Results from empirical studies have
shown that adherence to antidiabetic medications helps to achieve tight glycemic control,
reduce systemic and glomerular hypertension, decrease inflammatory processes, and
prevent metabolic syndrome (Kumar et al., 2010; Papadakis et al., 2015). Common
diabetic complications observed among the targeted population included: cardiovascular
diseases, diabetic retinopathy, diabetic nephropathy, and diabetic neuropathic foot ulcers.
Busko (2014) suggested that patients who are diagnosed with Type 2 diabetes
mellitus at a relatively young age are more susceptible to diabetic complications as they
get older. This may be due to the long-term effects of uncontrolled hyperglycemia on the
microvasculature and organs. According to findings from several studies, tight glucose
control reduces diabetic complications among people with diabetes (Shivashankar et al.,
2016; Medscape, 2017).
The result of this study showed that individuals with normal HbA1c (which
suggested normal glycemic control) within the previous 3 months, had less incidence of
cardiovascular disease, diabetic retinopathy, diabetic nephropathy, and diabetic
neuropathic foot ulcers. Nonadherence to medication among diabetic patients is alarming
(Blackburn et al., 2013). My data analysis showed that a greater number of the
individuals reported low adherence to treatment which was congruence to their measured
HbA1c levels.
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According to UKPDS (2018), it is essential to control glucose levels in order to
prevent hyperglycemia. Sustained and controlled hyperglycemia seriously damages the
nerves, blood vessels, and subsequently the major organs. These major organs may
include: eye (retinopathy), kidney (nephropathy), foot diseases (diabetic foot ulcers)
increased risk of heart attacks (cardiovascular diseases), and/or strokes. My data analysis
showed that low levels of adherence to treatment correlates well with cardiovascular
disease, diabetic retinopathy, diabetic nephropathy and diabetic neuropathic foot ulcer
after controlling for age and gender.
Interpretation of the findings
Age and diabetic complication
Age was controlled in this study; however, results of this study revealed that age
consistently correlate with all diabetic complications (cardiovascular disease, retinopathy,
diabetic nephropathy, and diabetic neuropathic foot ulcers). Data analysis showed that as
individuals advance in age the severity of diabetic complications increased. Advanced
aged individuals had more diabetic complications than the younger population. This
finding may be due to prolonged uncontrolled hyperglycemia.
Gender and diabetic complication
Gender was also controlled in this study and results indicated that gender was
statistically insignificant contributor to change in outcomes observed. The result of my
data analysis showed that being male or female does not increase the severity of any
diabetic complications.
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HbA1c (glycemic control) and diabetic complication
Results from numerous studies have shown that nonadherence to antidiabetic
medications makes the treatment of diabetes difficult and worsens diabetic complications
(WHO, 2017). According to Fischer (2017), the goal of antidiabetic medication is to keep
HbA1c within the normal range. The results of this study revealed that high levels of
HbA1c indicating poor glycemic control increased the severity of all diabetic
complications (cardiovascular disease, diabetic retinopathy, diabetic nephropathy, and
diabetic neuropathic foot ulcer). Nearly all the individuals with normal HbA1c were not
diagnosed and they did not report of any diabetic complications.
Adherence level and diabetic complication
According to Wilks et al. (2009), results from the 2007/8 JHLS revealed that only
40% of diabetics in Jamaica adhered to their antidiabetic medication, while 60% were
nonadherent. Findings from my study concur with the findings by Wilks et al. (2009). My
data analysis showed that majority of the people with diabetes reported low level
adherence (nonadherence) to antidiabetic medication. Most of the nonadherent
individuals had mild to severe diabetic complications.
Cardiovascular disease
The results from the data analysis for this study revealed that abnormally high
levels of HbA1c were statically significant predictors of low levels of adherence to
medication prescribed to treat diabetes. The theory of planned behavior has proven to be
useful in predicting behavior such as adherence. Levels of adherence could be predicted
based on consistent forms of attitude, subjective norm, perceived behavioral control,
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intention, and previous behaviors (Rich et al., 2015). The WHO (2010) report states that
people with diabetes have 2 to 3 times higher rates of cardiovascular disease than the
general population and nonadherent behavior makes it worse. The results from this study
revealed that majority of the patients that had experienced sustained uncontrolled
hyperglycemia had mild to severe cardiovascular disease. This finding supported the
findings of Amado et al. (2015) who suggested that nonadherence to treatment hinders a
patient from achieving tight glycemic control, hence making the patient susceptible to
diabetic complications. The outcome of this study also supported the findings by
Papadakis et al. (2015), which indicated that cardiovascular myopathy among people
living with diabetes was related to levels of adherence to treatment for diabetes.
Diabetic Retinopathy
Results from multiple regression analysis of this study revealed that abnormally
elevated HbA1c levels were statistically significant predictors of the severity of diabetic
retinopathy. This finding concurred with the finding of Wilks et al. (2009), who reported
that JHLS revealed that most people with diabetes in Jamaica had diabetic retinopathy
which was associated with nonadherence to treatment. The severity of diabetic
retinopathy increased as abnormal HbA1c levels increased indicating poor glycemic
control. The outcome of my data analysis confirmed the finding of WHO (2010), which
suggested that the prevalence and severity of diabetic retinopathy among individuals with
diabetes who have poor glycemic control is high. This finding is also the same as the
findings of Khaw, Shah, and Elkington (2010), which suggested that diabetic retinopathy
is a consequence of long period of uncontrolled glucose level.
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Diabetic Nephropathy
The findings of this study indicated that HbA1c and levels of adherence to
treatment had significant predictive relationship with diabetic nephropathy. According to
Woldu et al. (2014) people with diabetes who poorly control their blood glucose are at
greater risk of developing diabetic vascular complications that results in end organ
damage, particularly, the kidney (diabetic nephropathy), heart (cardiomyopathy), and
eyes (retinopathy). Medscape (2017) indicated that diabetic nephropathy is caused by
persistent hyperglycemia that leads to renal injury. The findings in this study indicated
that as abnormally high HbA1c increased, the severity of diabetic nephropathy increased,
and as level adherence decreased, the severity of diabetic nephropathy increased. These
findings supported the hypothesis that there is a predictive relationship between poor
glycemic control (high levels of HbA1c and nonadherence) and diabetic nephropathy.
The findings of this study confirmed the findings by Chang et al. (2015) that suggested
that patient nonadherence to antidiabetic medication puts a patient at higher risk of
developing end-stage renal disease (ESRD) when compared to patients who adhered to
antidiabetic medication.
Diabetic Neuropathic Foot Ulcer
Results obtained from the multiple regression data analysis for this study
explicated that abnormally high HbA1c levels were statically significant predictors of
low-level adherence to antidiabetic medications prescribed to treat diabetes.
The result of data analysis revealed that low level adherence to antidiabetic
medication was associated with mild to severe diabetic neuropathic foot ulcer. This
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finding supported the finding of WHO (2017) that suggested that the prevalence of
diabetic neuropathic foot ulcer is high, and it is directly associated with nonadherence to
antidiabetic medications. Mayo clinic (2017) also affirmed that diabetic neuropathic foot
ulcer is a late sequalae of diabetic complication caused by prolonged sustained
hyperglycemia due to nonadherence to treatment. This study has revealed that HbA1c an
indicator of poor glycemic control was significant predictor of the severity of diabetic
neuropathic foot ulcer.
Limitations of the Study
The data used for this study were collected at only one general hospital located in
a small town hence, a limitation to generalization of the outcome to the society at large.
The level of adherence was self-reported by the patients in response to Morisky-8 item
medication adherence scale questionnaire, as a result there may be issues regarding
trustworthiness. However, HbA1c was a significant predictor of level of adherence for
this study hence resolving questions regarding validity and reliability of the study
outcome.
There are other factors that could potentiate complications among people with
diabetes such as sedentary lifestyle, smoking cigarettes, obesogenic diet options,
advanced age, late or undiagnosed diabetes mellitus, and the use of complementary or
alternative medicine (Gemeay et al., 2015; Papadiski, 2015). These possible potentiating
factors are all beyond the scope of this study and hence were not measured. It is also
beyond the scope of this study to explore interventions that may enhance adherence
among the target group.
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Recommendations
The results of this study have revealed that low adherence (nonadherence) to
antidiabetic medication has a significant predictive relationship with diabetic
complications (cardiovascular disease, diabetic retinopathy, diabetic nephropathy, and
diabetic neuropathic foot ulcer). Therefore, I recommend further studies on the predictive
relationship between HbA1c and diabetic complications to expand the body of
knowledge. It is also important to study how to improve adherence among this targeted
populations while exploring factors affecting levels of adherence among diabetics in
Jamaica. In addition, Ferguson, Tulloch-Reid, and Wilks (2010) suggested that there are
few data addressing nonadherence and diabetic complications in the Caribbean region.
Hence, I recommend for more extensive studies in this area as such data may be essential
in planning effective strategies to combat the alarming prevalence of diabetes and its
complications in the region.
Implications of the Study
The implications of this study will be far reaching. Analysis of data from this
study had shown that low level adherence to antidiabetic medication continues to be a
significant public health challenge with high burden of diabetic complications. I expect
the outcome of this study to have positive effects at the individual level, family level,
hospital level and could stir up conversations about the benefits of medication adherence
and the traumatic consequences of nonadherence among the policy makers.
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Positive Social Change, Theoretical and Empirical Implications
The potential for positive social change at the individual level, will include an
adherent behavioral modification that may translate into tight glycemic control as well as
decreased severity of diabetic complication. The positive impact at the family level, may
include a healthier, happier and more productive family. At the organizational level,
diabetics that are adherent to their treatment are less likely to call off sick. Most
performance rating of healthcare facilities rely heavily on patient medication adherence.
When patients adhere to treatment plan readmission are reduced to a bearable minimum.
The outcome of this study has the potential to form the basis for serious
discussions among policy makers that could result in policies that could lend support to
diabetics in Jamaica. There are also methodological, and empirical implications of this
study; the methodology used in this study were already validated and used many times in
the past. However, the outcome of this study when published will add to few empirical
data available in the Caribbean region. further scientific investigations in this area, factors
affecting the prevalence of nonadherence in Jamaica and ways to improve adherence
among the target population. This study also has the implication for further scientific
investigations that may broadly exploring factors affecting nonadherence in Jamaica and
ways to improve adherence among the targeted population.
As shown in this study, HbA1c is a significant predictor of levels of adherence
and has strong relationship with diabetic complications. Therefore, I recommend that
health care providers should find creative ways to get their patients to take their
medications as prescribed. Health care providers should adopt a shared-responsibility
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approach; an approach that involves individual patients and their immediate families in
the plan of care, particularly medication adherence.
The American Diabetes Association (ADA) has clinical practice guideline
recommendations regarding the standards of medical care for management of diabetes,
which are updated regularly based on best available empirical data. Most recently
updated in 2018, these ADA guidelines are resources that health care providers must
follow to deliver optimal quality of care for improved patient clinical outcomes. It is true
that effective management of diabetes that prevents complications is an arduous task
since it influenced by behavior and complicated by social and economic conditions of the
patient. It is my recommendation that all these issues be addressed as part of the initial
plan of care.
Conclusion
Diabetes mellitus is a chronic, debilitating metabolic disease that targets multiple
organs, and has tremendous social and economic consequences. Due to the extensive
debilitating nature of the disease, there is an obvious expectation on the part of the health
care providers that patients will take their life and health seriously by taking their
medications as prescribed. However, when the health seeking behavior of a patient lacks
congruence with this expectation, there is always colossal traumatic consequences. In this
research I found that nonadherence to antidiabetic medications has significant predictive
relationship with diabetic complications. The severity of diabetic complications such as
cardiovascular diseases, diabetic retinopathy, diabetic nephropathy, and diabetic
neuropathic foot ulcer increases as abnormally high levels HbA1c increases.
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Given the outcome of this study, I can suggest that tight glycemic control as
evidenced by normal HbA1c, decreases the incidence and severity of diabetic
complications. This finding supports American Diabetes Association’s guideline for
management of diabetes mellitus in which they recommend that HbA1c levels should be
controlled at 7.0% or lower in other to prevent diabetic complications. Tight glycemic
control is achieved only by strict adherence to treatment plan. Adherence to prescribed
medications coincides with adequate motivation to adapt to lifestyle that integrates
medication as part of activities of daily living.
Non-adherent behavior could be predicted according to the theory of planned
behavior by considering an individual’s beliefs about antidiabetic medications, perceived
severity of diabetes and its complications, and knowledge about the benefits of adhering
to antidiabetic medications which outweighs the risk of potential side effects, minor
discomforts, and even the cost of the medication (Van Camp, Bastiaens, Van Royen, &
Vermeire, 2016). All health care providers should pay attention to the predictive adherent
behaviors of their patients and know the best corrective measures to apply in other to
achieve optimal treatment, hence reduce diabetic complications.
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